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ABSTRACT 
Doo Nam Kim: Computer-based Design of β-sheet Containing Proteins 
(Under the direction of Brian Kuhlman) 
 
 
Protein design is an excellent test of the minimal determinants of protein structure. Although 70% 
of naturally occurring proteins contain β-sheets, most previous design efforts have been limited to α-helix 
bundle proteins or the redesign of naturally occurring proteins.  Here, we test and develop computer-
based methods for designing proteins rich in β-strands.  The molecular modeling program Rosetta was 
used for three separate design tasks: (1) the design of α/β and α+β proteins with a new method called 
SEWING, which builds proteins from pieces of naturally occurring proteins, (2) the stabilization of β-
sheet proteins via the redesign of surface-facing residues, and (3) the de novo design of β-sandwich 
proteins. This research showed that it is possible to extend the SEWING method to non-α-helix proteins, 
allowing the incorporation of structural features found in nature, and that it is possible to dramatically 
boost protein thermal stability (> 25oC) with the redesign β-sheet surfaces.  However, we also found that 
the de novo design of β-sandwich proteins still remains an elusive goal.   
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“Yeah, the template file had this section.” 
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 CHAPTER 1: COMPUTATIONAL PROTEIN DESIGN 
Introduction 
Protein engineering is commonly used to improve the effectiveness and commercial value of 
therapeutics and research reagents.  For example, the DNA sequencing industry has benefited from re-
engineered DNA polymerases that allow for more efficient sequencing (1). Proteins can be reengineered 
to adopt a wide array of conformations. For example, compared to DNA origami assemblies that are 
limited Watson-Crick base pairs as a sole building block, protein assemblies allow more diverse 
directionality and conformations using electrostatic interactions, hydrophobic interactions, and hydrogen 
bonds between backbone and side-chain polar groups (2).  
The pharmaceutical market is by far the biggest sector in biotechnology, much larger than the 
nucleic acid sequencing or biomarker markets. Therefore, the pharmaceutical industry is one that drives 
the United States economy. Each year, the total nominal spending on medicines in the U.S. is $425 billion 
(3), and the industry supports around 3.4 million jobs. Pharmaceutical drugs are derived from chemical 
synthesis or are a result of biopharmaceuticals, which can include vaccines, recombinant proteins, stem 
cell therapies and others. Drugs can treat, or cure diseases of the human body.  
 
Protein as therapeutics 
In the pharmaceutical market, protein-based drugs such as antibodies and peptides are the fastest 
growing players due to lower toxicity and tighter specificity than more traditional small molecule drugs. 
Protein drugs tend to have little side effects other than some unwanted immunogenicity which can be 
reduced by prediction (4). While, the toxicity issue of the small molecules seems inevitable due to 
proteins’ inherent promiscuous interactions to small ligands (5). Proteins perform many critical functions 
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in our body. They protect the body against viruses and bacteria, transmits signals that coordinate 
biological processes between cells, tissues, and organs, and provide structure and support for cells. 
Therefore, it has been said that “Almost everything in biomedicine could be impacted by an ability to 
build better proteins”(6). Traditional small molecules can be good drug candidates due to their ability to 
bind to small pockets in proteins, oral administration, cheaper manufacturing cost, and better-studied 
ADMET properties. However, protein drugs are often more suited for controlling protein-protein 
interactions and need shorter and less expensive clinical trials compared to small molecules. Due to its 
very specific binding to a target with CDR, the antibody is also used as antibody conjugated small 
molecules (ADC: antibody drug conjugates). Even much expected mRNA based therapeutics by many 
companies including CureVac (7) and Moderna Therapeutics (8) rely on protein translation once the 
mRNA enters the body. Indeed, it has been mentioned that “Molecular recognition is a major part of what 
distinguishes biology from chemistry” (9). 
 
Computational protein design 
To maximize the usefulness of proteins, scientists have been computationally designing them 
using a variety of methods (10) (11) (12) (13). One established approach for rotamer-based sequence 
design is dead-end elimination, which removes rotamers that are not part of the global minimum energy 
conformation (GMEC) (14) (15) (16). However, for many design goals it is necessary to sample 
alternative backbone conformations, and in these cases the traditional dead-end elimination no longer 
guarantees that flexible-backbone GMEC will not be pruned (17).  
The Rosetta molecular modeling program (18) uses Monte Carlo simulations to search for low 
energy states. This simulation often efficiently converges energy minima due to its score function and 
rotamer library, which are best optimized to reproduce x-ray crystallography derived structures. The 
Rosetta community has been designing proteins for a variety of purposes including increasing the net 
charge of proteins (often called supercharging, this has been shown to improve the thermostability and 
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affinity of antibodies by up to 30-fold) (19) (20).  Rosetta has been used to design a variety of clinically 
relevant proteins including:  bispecific antibodies (21), protein inhibitors that bind to a conserved region 
of the hemagglutinin of an influenza virus (10), pH-sensitive IgG binding protein (12), protein binders 
that have high affinity and selectivity for a steroid molecule (22), and the removal of T-cell epitopes to 
reduce immunogenicity (4). Aside from design, the Rosetta program has been used for docking between 
hemagglutinin and monoclonal antibodies (23) and making predictions in order to improve catalytic 
activity (24). These computational protein designs are often need to be complemented or followed by 
experimental methods such as phage and yeast display (10) or single B-cell technology.  
 
Challenges in computational protein design 
Although there have been some successes (25) (26), protein interface design remains one of the 
most challenging goals in computer-based design (27). To address this protein interface design challenge 
more effectively, optimizing the protein design score function for interface design only (rather than 
common monomer design) was tried with some success (28) (29). The Shifman group believed that 
buried polar atoms often occurred at protein-protein interfaces. In addition to this, the group showed that 
increasing the weight of the electrostatic term led to some protein-protein interface design successes as 
seen from an antibody affinity maturation design case as well (30). Nature also uses explicit electrostatic 
interactions such as the 10 femtomolar Kd of the barnase-barstar protein complex (31). However, their 
claim of observing some buried polar atoms at native protein-protein interfaces is under active scrutiny 
because our group believes that buried polar atoms are hardly be found in native protein-protein 
interfaces, and these buried polar atoms often lead to failures in interface design (27). Other challenging 
computational protein design goals include de novo design and all β-sheet protein design (32). 
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Necessity of de novo protein design 
De novo design builds both backbones and sidechains from scratch (33). De novo design serves 
two main purposes; first, it tests our understanding of protein structure and folding, like Richard Feynman 
said, “what I cannot make, I do not understand”. Second, it opens the possibility of using previously 
undiscovered protein structures. Although more than 112,000 protein structures have been deposited (as 
of August in 2016) (34), it is believed that a much larger portion is still unexplored, when one considers  
the possible combination of secondary structure elements. For example, only 1,400 out of an estimated 
10,000 possible different protein folds have been identified (as of 2014) (35). Indeed, when I designed 51 
different β-sandwich, α/β, and α+β proteins de novo, no designed structure was the same as any of the 
already determined protein structures according to the Dali database (36). Therefore, it is assumed that 
there are many “never born proteins” (35). For example, among the four major classes of protein 
structures (Table 1.1), all β-sheet proteins (32) and non-repeat α/β proteins whose N and C-terminal (in 
primary sequence) regions that are located at the edge (in 3-D) have not been successfully de novo 
designed. 
 
 
Class SCOP (37) CATH (38) 
Number of folds Number of structures Number of folds 
Mainly α 284 7,534 397 
Mainly β 174 10,570 241 
α/β 147 11,853 626 
α+β 376 10,950 
 
Table 1.1 Number of protein folds and structures according to classes (May, 2015) (39). 
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Previous de novo protein design methods 
There have been numerous efforts to design proteins de novo since the design of ALPHA-1 (40) 
and Betabellin (41) (Table 1.2). Researches using Rosetta as their primary design tool have been 
designing proteins de novo mostly by “fragment insertion” (42), which replaces backbone torsion angles 
semi-randomly with those of either three or nine residue long extracted fragments (33) (43) (44). 
Although these fragment insertion methods have been successful, most of them are limited by “idealized” 
or “canonical” backbone geometries, which often fail to use nature’s distinct features (45). Furthermore, 
as stated by Jacobs et al. (46), backbone generation using repeating units is limited to native geometries of 
those repeating units (Figure 1.1) (47) (48).  
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Year Class Designer N-term & C-term (topologically) Design blocks for 
backbone 
Comment 
2003 α/β Kuhlman 
(33) 
At least one terminal is located in 
the middle 
3 or 9 residues long 
fragments 
Very stable design (“top7”) 
2012 α/β Koga (43) At least one terminal is located in 
the middle 
3 or 9 residues long 
fragments 
Design of five folds 
2014 Α Joh & 
DeGrado 
(49) 
Both N and C-terminals are located 
at the edges 
Tertiary templates Stochastic search of 
parameterized backbone 
geometries in the space of 
Crick parameters 
2015 Includes 
α/β 
Parmeggia
ni (47) 
Some designs have N and C-
terminals that are located at the 
edges 
Naturally occurring 
repeating units 
Guided by constraints 
derived from existing 
structures 
2015 α/β Lin & 
Koga (50) 
At least one terminal is located in 
the middle 
3 or 9 residues long 
fragments 
Design of seven folds 
2015 α/β Park (48) Both N and C-terminals are located 
at the edges 
Naturally occurring 
repeating units 
Guided by constraints 
derived from existing 
structures 
2015 Α Brunette 
(46) 
Some designs have N and C-
terminals that are located at the 
edges 
Repeating a  
α–loop–α–loop 
structural motif 
α helix bundle design 
2015 Α Murphy 
(51) 
At least one terminal is located in 
the middle 
3 or 9 residues long 
fragments 
α helix bundle design 
2015 Α Doyle & 
Bradley 
(44) 
Closed architecture 3 or 9 residues long 
fragments 
α helix bundle design 
2015 α+β Marcos 
(52) 
At least one terminal is located in 
the middle 
Parametric geometric 
constraints 
Used naturally conserved 
sequences 
2016 α/β Huang 
(53) 
Closed architecture 3 or 9 residues long 
fragments 
Guided by geometric 
constraints derived from 
existing structures 
2016 Α Jacobs 
(45) 
At least one terminal is located in 
the middle (CA01) 
Super secondary 
structures 
α helix bundle design 
2016 Α Boyken 
(54) 
At least one terminal is located in 
the middle 
Parametric geometric 
constraints 
α helix bundle design 
2016 α/β, α+β Kim (this 
thesis) 
Both N and C-terminals are located 
at the edges 
Super secondary 
structures 
Used bigger super 
secondary structures than 
smotif (55) 
 
Table 1.2 Some Examples of Computational de novo Protein Designs. I listed those designs whose 3-
D structures were determined at least by secondary structure level experimentally. I excluded sidechain-
only de novo designs with native backbones as redesigns (15) (16) (56) (57). There are more de novo 
designs especially that were done by the non-Rosetta community (35), however I did not introduce them 
here.  
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Figure 1.1 Overview of repeat protein design protocol (47) 
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Supersecondary structure based de novo protein design method (SEWING) 
To capture nature’s unique geometric features, Jacobs et al. used protein supersecondary 
structures called “smotif” (45) (55) (58). Through this method, they were able to design helix backbone 
geometries that captured nature’s unique features. They named this process “SEWING” (Structure 
Extension WIth Native substructure Graphs). They could extract not only native backbone geometries but 
also native sidechains that are often responsible for important capping, packing, hydrogen bonding and 
electrostatic interactions (Figure 1.2). 
 
Figure 1.2 Overview of the SEWING method. (A) Contiguous SEWING workflow. (B) Discontiguous 
SEWING workflow. Each panel, from left to right: parental PDBs with extracted substructures; Graph 
schematic colored nodes indicate substructures contained in final design model, superimposed structures 
show structural similarity indicated by adjacent edges; Design model before sequence optimization and 
loop design; Final design models (58). 
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Conclusion and following chapters 
Protein engineering is important to better use protein’s intrinsic biological properties. 
Computational protein design has been utilized because it reduces the time and cost of protein 
engineering. However, de novo design remains relatively challenging, especially when trying to preserve 
nature’s unique geometric properties. To address this challenge, Jacobs et al. developed a new backbone 
design method, named SEWING, which has shown its α-helix bundle design capability. Chapter 2 
describes our efforts to apply this SEWING method to non-α-helix proteins, such as non-repeat α/β and 
α+β proteins. Chapters 3 and 4 focus on β-sandwich protein designs. Chapter 3 shows the charge zipping 
of β-sandwich proteins in an effort to induce the desired folding order of complex Greek key motif 
proteins. Chapter 4 presents various approaches for de novo design of β-sandwich proteins including the 
SEWING method. 
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CHAPTER 2: COMPUTATIONAL DE NOVO DESIGN OF A/B AND A+B PROTEINS 
Introduction 
α/β class proteins have alternating secondary structures of α-helix and β-strand. Examples of α/β 
topology include βαβαβαβα and βαβαβαβ. Another topology are the α+β class proteins which have β-
meander structure(s) and are often found in single stranded RNA binding proteins (59). The common 
structure of this α+β topology is αββββα. Although these α/β and α+β class proteins constitute 
significant portions of whole protein structures (Table 2.1), there is only one successful de novo design 
for α+β class so far (52). Previous de novo designs for α/β class proteins are also fewer than those for α-
class proteins. Additionally all designs in this class, except repeat protein designs, have at least one 
terminal region (in primary sequence) that is located in the middle (in 3-D space) (Table 1.2). 
 Therefore, we tested whether we can design small globular non-repeat proteins that have N and 
C-terminal regions that are located at the edges. We were not sure whether this type of protein topology 
of a small size (less than 100 residues) could even stably fold. Because, when we searched our designed 
structures against all previously determined protein structures (36), we got only larger proteins containing 
this type of topology as the closest structures.  
This ambitious design trial was done with a new backbone design method, SEWING (introduced 
in chapter 1). Firstly, we used three secondary structures as substructures for backbone assembly as 
Jacobs et al. used (45) to design α+β proteins. Then we used five secondary structures as substructures for 
backbone assembly to design α+β and α/β proteins (Figures 2.1, 2.2 and 2.3). 
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(a) (b)  
(c)  
Figure 2.1 Selected design models that cooperatively unfolded. a) “m4”, one of the α+β designs that 
used three secondary structures as substructures for backbone assembly, b) “ab2”, one of the α+β designs 
that used five secondary structures as substructures for backbone assembly, c) “en8”, one of the α/β 
designs that used five secondary structures as substructures for backbone assembly 
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a)  b)  
Figure 2.2 Application of SEWING method using small substructures. a) An example showing how 
two sets of three secondary structure based substructures are merged, b) An example of merged two β-
hairpins. Black boxes represent regions that are used for superimposition. 
 
 
Figure 2.3 An example that two large substructures are merged 
 25 
Computational Design and Experimental Results 
Design with three secondary structure substructures 
Using the previously described SEWING method (Chapter 1), I designed non-helix bundle 
proteins (α+β) using HLE, ELE, and ELH substructures (H: helix, L: loop, E: strand) (Figure 2.2). I 
assembled substructures only when they have at least 10 superimposable backbone atoms. However, none 
of the eight expressed designs (m1~8 stands for meander proteins) were stable enough for 3D structure 
determination (Table 2.1). Interestingly, even the disulfide bonded designs (including m4_ss2, m8_ss1) 
either aggregated before 1-D NMR or unfolded. However, at least these disulfide-bonded designs had 
improved melting temperatures than original non-disulfide bond designs as shown by later cooperative 
thermal unfolding. Therefore, these may indicate that although these designs folded into certain globular 
proteins, they might just lack further stability for 3-D structure determination. Therefore, I designed larger 
eight α+β designs (bab 1~8 stands for bigger α+β proteins), because larger proteins tend to be more 
stable (60) (61). However, most of these designs were not expressed as stable proteins either. 
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Design 
name 
Residue 
length 
Expressi
on 
Size exclusion CD Folding Verdict 
m1 70 Yes Single peak coil  Not folded 
m2 68 Yes Single peak coil  Not folded 
m3 68 Yes Single peak coil  Not folded 
m4 68 Yes Single peak α+β 47.6oC Tm Aggregated before 1-D NMR  
m4_ss2 73 Yes Single peak α+β 47.8oC Tm Aggregated before 1-D NMR 
m5 65 Yes Single peak   Not cleaved from SUMO by 
ULP1 
m6 65 Yes Single peak coil  Not folded 
m7 71 Yes Single peak coil  Not folded 
m8 71 Yes Single peak α+β 37.4oC Tm Aggregated before 1-D NMR 
m8_ss1 76 Yes Single peak coil   
bab1 81 Yes 
(little) 
   Expression yield is too low 
bab2 72 Yes 
(little) 
   Expression yield is too low 
bab3 76 Yes Single peak coil No 
cooperative 
unfolding 
Not folded 
bab4 74 No     No expression 
bab5 78 Yes Soluble 
aggregation 
  Aggregated 
bab6 80 Yes    Not cleaved from SUMO by 
ULP1 
bab7 78 Yes    Not cleaved from SUMO by 
ULP1 
bab8 75 No    No expression 
 
m8    bab2 
 
 
Table 2.1 Experimental results of α+β proteins using conventional small substructures (smotif).  
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Design with five secondary structure substructures 
Nature often has important backbone geometrical features that aren’t typically considered in de 
novo design. Therefore, to utilize native geometric backbone features more, we extracted larger 
substructures. Instead of conventional three secondary structure substructures, we extracted five 
secondary structure substructures (e.g. HLELE, ELELE, ELELH where H is helix, L is loop, and E is 
strand) and assembled them with monte carlo backbone assembly within the SEWING protocol (Figure 
2.3). Unlike the previous approach, I assembled substructures only when they had at least 16 
superimposable backbone atoms to favor capturing more designable backbones. Among the eight α+β 
designs, two designs (ab1, ab2) seemed to be well folded and cooperatively unfolded according to CD and 
HSQC results (Figures S2.1, S2.2). However, they were multimeric (Table 2.2) and did not express 
enough for 3D structure determination even with increased level of glucose in LB media and auto-
induction media. In addition to α+β proteins, I also designed α/β proteins using five secondary structure 
substructures (e.g. ELHLE). These eight α/β designs were named en1~8 which stand for enumerated 
SEWING assembly of substructures. Backbones of these α/β were generated after exhaustive 
enumerations of five secondary structure based substructures (62), because regular monte carlo backbone 
assembly in SEWING protocol did not generate diverse designable backbones due to limited five 
secondary structure based substructures in PDB (34). Among the eight α/β designs, one design (en8) was 
expressed to the highest yields and folded quite stably according to HSQC (Table 2.3) (Figures 2.4, 2.5 
and 2.6). The low expression yield of ab1, ab2, ab6, en4, en6 may be due to computational design failure 
or unexpected toxicity of these proteins in E. coli or unexpected ribosomal interaction or other 
complexities of the bacteriums’ biology (63). 
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Design 
name 
Protein  
length 
Express
ion 
Size exclusion 
chromatography 
CD Folding Verdict 
ab1 74 Yes Single peak α+β  Cooperati
ve 
unfolding 
Well-folded (CD). However it 
tetramerized (MALS), and not well 
expressed for 3-D structure 
determination. 
ab2 74 Yes Single peak α+β  Cooperati
ve 
unfolding 
Well-folded (CD, HSQC). However 
it dimerized (MALS, NMR), and 
not well expressed for 3-D structure 
determination 
ab3 74 Yes    Not cleaved from SUMO by ULP1 
ab4 74 Yes    Not cleaved from SUMO by ULP1 
ab5 74 Yes    Not cleaved from SUMO by ULP1 
ab6 74 Yes    Expression yield is too low 
ab7 74 Yes Soluble 
aggregation 
  Aggregated 
ab8 74 Yes Single peak Coil  Unfolded 
 
Table 2.2 Experimental results of α+β proteins using largesubstructures.   
 
 
Design  
name 
Protein  
length 
Expression Size exclusion 
chromatography 
CD Folding Verdict 
en1 75 Yes Single peak α/β No cooperative 
unfolding 
Unfolded (1-D NMR) 
en2 75 Yes Single peak α/β No cooperative 
unfolding 
Unfolded (1-D NMR) 
en3 75 Yes Single peak α/β No cooperative 
unfolding 
Unfolded (1-D NMR) 
en4 75 Yes Single peak   Not that well expressed 
en5 75 Yes Single peak α/β No cooperative 
unfolding 
Unfolded (1-D NMR) 
en6 82 Yes Single peak   Not that well expressed 
en7 83 Yes Single peak α/β Cooperative 
unfolding 
Unfolded (1-D NMR) 
en8 83 Yes Single peak α/β Cooperative 
unfolding 
Well-folded except 1-20 
residue region (CD, NMR). 
Dimer (MALS, NMR) 
 
Table 2.3 Experimental results of α/β proteins using large substructures.   
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a) b)  
c)  d)   
 
Figure 2.4 en8 structure and its closest structure in nature.  
a) Designed structure of en8, red stick representation shows backbone oxygen atom of glycine at the 6th 
position, which could lack a satisfied hydrogen bond although it may be buried.  
b) en8 (green) and its structurally closest structure (red) in nature (pdb code: 3der, chain A, 2.3 Å rmsd 
with en8 and 8.4 Z-score) according to Dali (36). 
c) en8 (cyan) and its structurally closest structure (rainbow). 
d) en8 (cyan) and its structurally closest structure (rainbow) with its original structure show that en8 
structure seems feasible because there is no too close native backbones to a corresponding structure.  
Except b), all illustrations were done by pymol (64). 
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Figure 2.5 HSQC of en8 protein. Well dispersed amide peaks show well-foldedness of the protein 
(400μM protein, in pH 7.0 20mM sodium phosphate + 150mM NaCl buffer, provided by RamaKrishna 
Pulavarti in Szyperski group) 
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a) 
 
b) 
 
c) 
 
d) 
 
 
 
Figure 2.6 CD spectra of en8 protein.  
a) A full spectrum at 20oC (after extracting buffer only values, 30μM protein, 0.1mm width cuvette). 
b) A full spectrum at 70oC. All other conditions are same as a). 
c) Thermal melt (20μM protein, 1mm width cuvette, started after staying 10 minutes at 5oC, ramped 2oC 
per minute). 
d) Denaturant unfolding (30μM protein, 1mm width cuvette, GuHCl is in mol) 
All CD values are mean residue ellipticity (deg*cm2/dmol) and were taken at pH 7.0 20mM sodium 
phosphate + 150mM NaCl buffer. 
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Increase net charge in an effort to monomerize well-folded α+β and α/β proteins 
Both MALS and NMR rotational correlation time from 15N average spin relaxation (τc of en8 is 9 
nano second, usually 0.5 ns/kDa) showed that the en8 is a homodimer in various protein concentrations 
and buffers (Table 2.4). MALS also showed that ab1 and ab2 are 4mer and homodimer, respectively. 
Multimerization of proteins is often necessary for distinct biochemical and biophysical properties, which 
additionally regulate functions at the post-translational level (65). However, we initially designed these 
proteins as a monomer. Additionally, the 3D structure determination of a monomer is easier than for a 
multimer. 
Therefore, in an effort to monomerize en8, ab1, and ab2 designs, we supercharged them using the 
supercharge protocol in Rosetta (supercharge means increasing net charge into either the positive end or 
the negative end) (20). The rationale for increasing net charge is that net charges are expected to govern 
overall intermolecular interactions by affecting electrostatic interactions between surface residues, as a 
simulation study has shown, that net charges do influence long-range orientational distribution of the 
water surrounding the protein surfaces (66). Therefore, we expected that high net charged proteins tend to 
have more unfavorable interactions between monomers, preventing unwanted non-covalent or covalent 
formation between monomers.  
However, all supercharged proteins were still multimeric according to MALS. For example, 
en8_-6, which was supercharged to -6 net charge from -1 net charged en8, was dimerized still. Ab1_-7, 
which was supercharged to -7 net charge from -3 net charged ab1, was folded as 4mer as well. Because 
the high net charge (-6) and the high salt concentration (1M NaCl) did not monomerize the dimerized en8, 
and because high TMAO (1.8M) made en8 even a 5mer, we hypothesized that en8 is a domain swapped 
obligate dimer rather than a transient electrostatic interaction derived dimer. This is a very preliminary 
idea, however the failure of crystal formation for en8_-6 with MCSG1~4 reservoir buffers (in total, 4 
plates at 20oC with various protein concentrations did not produce protein crystals) may indicate that the 
en8_-6 is still partially unfolded. Because, it is widely believed that crystallography with flexible proteins 
is harder than stable proteins (67). 
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Design 
name 
Net 
charge 
Length 
Size exclusion 
chromatography 
MALS CD 
Buffer and protein concentration Oligomerization 
Determination 
ab1 -3 74 Single peak 20mM Na phosphate pH 7.0, 
150mM NaCl, 500 μ0 
4mer 
 
α+β 
ab1_-7 -7 74 Single peak 20mM Na phosphate pH 7.0, 
150mM NaCl, 760 μ0 
 
ab2 -2 74 Single peak 
 
20mM Na phosphate pH 7.0, 
150mM NaCl, 113 μM 
Dimer α+β 
en8 -1 83 Single peak 20mM Na phosphate pH 7.0, 
150mM NaCl, 840 μ0 
Dimer 
 
α/β 
20mM Na phosphate pH 7.0, 1M 
NaCl, 621 μ0 
 
20mM HEPES-KOH pH 7.4, 
150mM NaCl, 1mM DTT, 651 μ0 
 
20mM Na phosphate pH 7.0, 1.8M 
TMAO, 651 μ0 
 
en8_-6 -6 83 Single peak 20mM Na phosphate pH 7.0, 
150mM NaCl, 800 μ0 
Dimer α/β 
en8_A11V -1 83 Single peak 20mM Na phosphate pH 7.0, 
150mM NaCl, 500 μ0 
Dimer  
en8_S8T_
A11V 
-1 83 Single peak 20mM Na phosphate pH 7.0, 
150mM NaCl, 500 μ0 
Dimer  
 
Table 2.4 Experimental results of original and supercharged α/β and α+β proteins.  
 
 
 
 
 
 
 
 
 34 
Reversion design in an effort to monomerize and better fold en8 design 
Predicted secondary structure by NMR showed that only residue numbers from 1 to 20 did not 
fold as we designed (Table 2.5). This partial unfolding of N-terminal region might have led to this 
possible domain swapping and failure of crystal formation for en8 with MCSG1~4 reservoir buffers (in 
total, 43 plates at 4~20oC with various protein concentrations did not produce crystals). There are possible 
reasons of this domain swapping. One is the possible existence of one buried unsatisfied backbone polar 
atom in the N-terminal region (Figure 2.1). However, it was not sure whether this backbone oxygen atom 
of glycine at the 6th position really lacks the needed hydrogen bond as both Kevin Houlihan’s buried 
unsatisfied hydrogen bond detector and Foldit (68) did not identify it as a buried atom with an unsatisfied 
hydrogen bond (Figure 2.7). Consequently, we postulated that by introducing a few native interactions 
back in might prevent this domain swapping by offsetting the potential destabilizing effect of a buried 
unsatisfied polar atom in the N-terminal region.  
Therefore, we came up with two reverted designs: en8_A11V, and en8_S8T_A11V (Table 2.6). 
We reverted alanine to valine at the 11th position (en8_A11V) because the presence of alanine in core or 
interface area is often not desired in many cases (53) (10). The reason that Rosetta chose the alanine at the 
8th position in N-terminal helix for the original en8 design could be that alanine has the best helical 
propensity, while valine has the 7th worst helical propensity among all 20 canonical residues (69). Indeed, 
mutating less helical residues into alanine often improves stability of α-helices (70). However, nature (the 
original pdb structure that SEWING used, UDP-GlcNAc 2-epimerase, pdb code: 4NES) may have used 
valine at the 8th position in helix to better fill the core void (Figure S2.3). The rationale for 
en8_S8T_A11V was that nature might have used threonine for the 8th position for a reason perhaps better 
capping the helix terminal region (Figure S2.4) in addition to a previously explained A11V. These 
redesigns of the N-terminal region seem plausible because the N-terminal and the C-terminal are designed 
as not interacting with each other. Protein sequence is known to govern protein folding, at least for a 127 
residue-long protein (71). However, I suspected that if the protein’s terminal regions are interacting with 
each other, redesign of one terminal region might make the protein fold totally differently. A partially 
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folded protein (“DA05”) of Jacobs (45) had N and C terminals, which are distant to each other as well, 
and C-terminal redesign made the DA05 to fold completely (Figure 2.8). However, both reversions 
(en8_A11V and en8_S8T_A11V) dimerized as the original en8 did. Both reversions are currently 
undergoing crystal trials. 
 
 
 
Secondary Structure Residue # (designed) Residue # (Talos) Residue # (CSI) 
N-terminal loop 1 1-2 1-12 
β-strand (I) 2-5 3-4 None 
α-helix (A) 9-20 11-16 13-15 
β-strand (II) 25-30 24-30 24-30 
α-helix (B) 34-49 32-49 32-49 
β-strand (III) 54-59 54-59 53-59 
α-helix (C) 63-76 63-75 64-75 
β-strand (IV) 79-82 79-82 78-82 
C-terminal loop 83 83 83 
 
Table 2.5 Predicted Secondary Structure of en8 by NMR (RamaKrishna Pulavarti in Szyperski lab 
confirmed that this en8 sample was fresh when he took NMR. Therefore en8 seems inherently partially 
folded). 
 
 
 
Figure 2.7 Buried unsatisfied hydrogen bond analysis. In this en8 designed structure, polar atoms 
without satisfying hydrogen bonds are represented as glowing red. One red glowing blue atom in red box 
represents backbone nitrogen of asparagine at the 7th position. Kevin Houlihan’s buried unsatisfied 
hydrogen bond detector identified residue 3, 23, and 24 have possible unsatisfied hydrogen bonds, not 
residue 6. The analysis was done by Foldit (68). 
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Design name Normalized REU Holesa) Packstata) Folding scoreb) Oligome
rizationc) 
En8 -2.46  (-2.50 ~ -2.43) 0.69  (0.43 ~ 
0.92) 
0.68  (0.63 ~ 
0.70) 
0.72 (7,000 
decoys) 
Dimer 
(MALS) 
En8_A11V -2.48  (-2.49 ~ -2.47) 0.86  (0.76 ~ 
1.02) 
0.68  (0.65 ~ 
0.71) 
0.61 (5,000 
decoys) 
En8_S8T_A11V -2.47  (-2.49 ~ -2.45) 0.71  (0.37 ~ 
1.01) 
0.67  (0.62 ~ 
0.71) 
0.75 (5,000 
decoys) 
 
Table 2.6 Reverted and original α/β and α+β proteins. Normalized REU is the total Rosetta score 
divided by total number of residues. All scores were calculated with talaris2014_cart score function after 
being relaxed. Each value of normalized REU, holes and packstat show mean (minimum ~ maximum).  
a) Both holes and packstat show how well a designed structure is packed. Lower value of holes or 
higher value of packstat means better packed. 
b) Folding score shows how forward-folding is funnel like (Equation S2.1). Essentially this represents 
how designed sequences are predicted to have designed secondary structures. Higher value of folding 
score means better funnel like (higher likelihood that designed protein will actually fold as designed). 
c) All three proteins were eluted as single peak from size-exclusion and went through MALS at 20mM 
Na phosphate pH 7.0 150mM NaCl as 500 micro M. 
 
Figure 2.8 An example of C-terminal redesign. Design models of DA05R1 (purple) and DA05R2 
(orange) superimposed on the original DA05 design model (gray). Because Jacobs et al. redesigned C-
terminal region which is distant from N-terminal region, these redesigns may have been easier than the 
redesign of proteins whose C and N-terminal are near each other (58). 
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Redesign with refolding in an effort to monomerize and better fold en8 design 
Because the two reverted redesigns (en8_A11V and en8_S8T_A11V) are still dimers, we 
completely redesigned the first 24 n-terminal residues by traditional ab initio refolding. Four redesigns 
(en8_re01, en8_re02, en8_re03, en8_re04) that are believed to satisfy three redesign goals are chosen for 
experimental validation (Figure 2.9). The first goal was to redesign the n-terminal α-helix to be nearer to 
the next α-helix because we believed that more closely packed secondary structures would be easier to 
design and more commonly found in nature. The second goal was to lengthen the n-terminal β-strand so 
that it has more hydrogen-bonds between it and the next β-strand. For example, the original en8 design 
had five backbone-backbone hydrogen bonds between the n-terminal β-strand and the next β-strand. On 
the other hand, refolded redesigns have seven to eight hydrogen bonds between these two β-strands. The 
third goal of this redesign was to remove possible polar atoms with unsatisfied hydrogen bond (Figure 
2.7). Specifically, we tried to design backbone polar atoms to not face toward core of proteins as in the 
first successful de novo design of a globular protein (33). However, en8_re01, en8_re02, and en8_re04 
were dimerized again (en8_re03 was not expressed enough). These are strong indications that an interface 
for this dimer is not likely the N-terminal region. Therefore, redesign of C-terminal region to have 
disulfide bond is underway. Having a disulfide bond in c-terminal such as between C-terminal beta-strand 
and C-terminal alpha-helix will likely lock up these two secondary structures to prevent possible domain 
swapping. Therefore, four redesigns of en8_re04 to have a disulfide bond were done and will be 
experimentally characterized. There are other ideas of preventing domain swapping such as having 
glycine or proline in loop, or a shorter loop (72) (73) (74). However, en8 already has glycine in its loop 
that connects the C-terminal beta-strand and C-terminal alpha-helix. It is not certain whether the existence 
of proline in the loop helps to prevent or induce the domain swapping. The en8 has already short loops. 
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Figure 2.9 The original en8 structure (in cyan) and one of the refolded redesigns (en8_re01 in green).  
 
 
Conclusion  
We have designed α/β and α+β proteins using supersecondary structures. One of the designs, 
en8, was expressed to high levels and mostly well folded. This is a significant improvement of 
computational protein design because it is the first proof that we can de novo design small globular non-
repeat α/β proteins whose N- and C-terminals are located at the edges (while, the sequence repetition of 
repeat proteins probably favor designed structures with internal repeats over alternative structures (63)). 
Additionally, this type of simple topology may serve as a nucleic acid binder (67). However, the original 
en8 design protein was a dimer and its N-terminal region (1~20 residues region) was partially unfolded. I 
have redesigned en8 into seven different variants in an effort to make it more well-folded. However, all of 
them are either dimerized or not expressed enough. Four new designs of en8_re04 that have a disulfide 
bond will be experimentally characterized. 
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Figure S2.1 Biophysical characterization of ab1 protein.  
a) A full spectrum at 20oC (after extracting buffer only values, 30μM protein, 0.1mm width cuvette).  
b) A full spectrum at 80oC. All other conditions are same as a). 
c) Thermal melt (15μM protein, 1mm width cuvette, started after staying 10 minutes at 5oC, ramped 2oC 
per minute). 
d) Denaturant unfolding (15μM protein, 1mm width cuvette, GuHCl is in mol), All CD values are mean 
residue ellipticity (deg*cm2/dmol) and were taken at pH 7.0 20mM sodium phosphate + 150mM NaCl 
buffer. 
e) 1D-NMR with 31μM of ab1 protein with 64 scans at 25oC. The verdict whether the protein is well 
folded is inconclusive because of low sensitivity.  
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c) 
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e)  
Figure S2.2 Biophysical characterization of ab2 protein.  
a) A full spectrum at 20oC (after extracting buffer only values, 30μM protein, 0.1mm width cuvette). 
b) A full spectrum at 80oC. All other conditions are same as a). 
c) Thermal melt (15μM protein, 1mm width cuvette, started after staying 10 minutes at 5oC, ramped 2oC 
per minute). 
d) Denaturant unfolding (15μM protein, 1mm width cuvette, GuHCl is in mol), All CD values are mean 
residue ellipticity (deg*cm2/dmol) and were taken at pH 7.0 20mM sodium phosphate + 150mM NaCl 
buffer. 
e) HSQC with 100μM of ab2 protein. The minor peaks seem to arise from minor contaminant (SUMO) 
rather than sample’s heterogeneity (provided by RamaKrishna Pulavarti in Szyperski lab). 
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Equation S2.1 Folding score equation. Value of λ is used as 2, kb is Boltzmann constant, Ei is total 
Rosetta energy with ith decoy (provided by Tom Linsky and Vikram Mulligan in Baker lab) 
 
a)         b)  c)  
Figure S2.3 Differences of helix capping between side-chain oxygen of the 8th position and backbone 
nitrogens of 10E and 11A. a) original en8 design with serine at the 8th position, b) en8_S8T design, c) 
native backbone that was used as substructure (node) during SEWING backbone assembly 
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a)     
b)	   	  	  c)  
Figure S2.4 Analysis of void in core region.  
a) Native backbone for en8 design in green, 11V in native backbone in blue, designed backbone for en8 in 
magenta, 11A in designed backbone in salmon. 
b) Void represented with red spheres in en8 design. 
c) Void represented with red spheres in en8_A11V design. A11V reversion in white shows reduced void 
volume in core region. Void was represented by foidit (75). 
 
 
 
 
 
 
 
 
 
 45 
[protein sequences used for this de novo design for α/β and α+β] 
 
> m1 
GDERKKKLEKKGFDVRKYEVRRNGEPKGYAVMAEKNGYWEIYVEENGQEKKETASTTEVAKRRVEKVMRL 
> m2 
TEEAKKAAELAKRAGDTGTEQQITLSQGREIRAWPNDDGSYVEIDTGKTTVRMPNAAEAAKQAAKAAN 
> m3 
TEEAKEAAKRAEEAGKKGTEMQITVSKGREFRVWPNSEGSTVQIDTGKTTYTASNAEEAAKVAKKAVN 
> m4 
ESDFEEAVERAKRGEQVTYKNESNGTILEIRPTSQRFEFWRIENGEKRKKAEVRGNNDDEMKRAAKEN 
> m4_ss2 
GCGESDFEEAVERAKRGEQVTYKNESNGTILEIRPTSQRFEFWRIENGEKRKKAEVRGNNDDEMKRAAKENGC 
> m5 
LDEVLKRIEEIYKKGQKIAFRADVNGNELEVRLDGDTIEFWLNGEKKSEVTGDDMDKVKEEMMRF 
> m6 
GERARKRFEEAGFETEKRGNEIYARYNGVEVKIIHDNGREETTAKMDPRDPEQQKAKERAERAAQ 
> m7 
TEHQKEIEKVREKAEKRGAPVETRGDTIRVEEPDGTHAFYQIHGQTTRATTTTNPEEGEKKAREEAKKDSE 
> m8 
VRDELFELAMRAGKHPGQTFEYKDEDNNIIIRFTPTEVRAFKNGEQKYTFKRDPREPEQAKAAAEDAEKAL 
> m8_ss1 
CGGVRDELFELAMRAGKHPGQTFEYKDEDNNIIIRFTPTEVRAFKNGEQKYTFKRDPREPEQAKAAAEDAEKALGC 
>bab1 
TSEAQEEWRKRAEKAAREAKTKNKRVELYLTGPNNRVIRIEVWVDSNGNGQVNAYADGQYFEVRTEDPTKAIEEAFKRAMN 
>bab2 
VAADKAREIFEKTGSSHVTAQGTLNGITFEVHYHPGGAELRFEFRDGDTVQRRRYQHSSLEEAERRAREAAK 
>bab3 
SDAEEIKKRLMKHPQGTIEVPVDSERRIYVESHDGRVEVRLYRNGQPERQTETSYPDGREHTWEAAAKKAEEYKRL 
>bab4 
TPKRHNEQAKEMHKNGYQTKKTQQNGNTFFLFIEYRDGNETHMYIFVFRGTEQREYHTKEPREFAELEKKARNL 
>bab5 
GDEEKERIREALEKGQEAHIKTTGGGQEILIIVRHENGKYRMEIRLNGEPQVERPNQSQEQLVKEAAKHAQELAERAK 
>bab6 
TEDDIKKAKELFKKLKEGKLQTIHARIQHDHGREIRIEARKKTDNEIEIRVWFYDGNKTEEMRFTEPDEAARRAEERAKS 
>bab7 
TEERIRDTKQEAHDKGFQTRTEKTERMNGQDYYFLIIEGGGIWFAFVFKEDKDNNQETRFTATGSSPEEAERRARKKA 
>bab8 
STIDKIREKFKRNGGEEVQIRYSKGYWIFIIRKPGNVIHVFVFLNGELKIHLVFDASKYDPEQARAEAEKEIEKQ 
> ab1_mc_16_atoms_00210165_0189 
TEAEKYATEIEKRLREKGIEARTYKKGNGIVIVAWDSTKIHVWIATEDTVKHVETTASEEQLKELIRQFMEEAI 
>ab1_-7 
TEAEKYATEIEKRLREDGIEARTYKEGNGIVIVAWDSTKIHVWIATEDTVKHVETTASEEQLKELIRQFMEEAI 
> ab2_mc_16_atoms_00210165_0237 
TEARKYATEIEKRLREKGIEARRIEKGNGIVIVAFDSTKYHVYIATEDTVIHIETTASEEQLKELLRQFMELAI 
>ab2_-7 
DEARKYATEIEKRLREDGIEARRIEEGNGIVIVAFDSTKYHVYIATEDTVIHIETTASEEQLKELLRQFMELAI 
> ab3_mc_16_atoms_00210165_0389 
TEAEKYAEEIKRRLEKKGIEARRIKKGNGIVIVAYDSTKYHIYIATEDTVTHLETTASDEQLKELIRQAMETAI 
> ab4_mc_16_atoms_00448602_0088 
TYAEEMARKIMEELQKRGITATMFRSGNGIVIVTWDSTSWHFFVATSTRVEHYETTASEDQARKILEEFMKRAI 
> ab5_mc_16_atoms_00448602_0252 
TIAEELARQIQEELDKRGITAQEYRSGNGIVIVWWDSTSWHFHVATSTRVEHYETTASEDQARKLTEEYIRRAE 
> ab6_mc_16_atoms_00448602_0276 
TNAQEAARKIEEELRKRGITATRYETGNGIVIVTWTSTSWHFFVATDTRVEHYETTASEDEARKLTKKYMKRAI 
> ab7_mc_16_atoms_00448602_0371 
TTAQEYARQIEEELRKRGITATVYETGNGIVIVHWDSTSWHFWVATETHVEHYETTASEDQARKLAKQYQREAI 
> ab8_mc_16_atoms_00583666_0072 
TEAQKVAEELRRRMEDKNQTGEIRVTDGEVEFRIRSGTEEAHVRIENGQTTTVTVKGSTKEEEKKKAEKYREEV 
> en1_144244_19_7_0114 
TYEITGGDEEAAKKAEEWWRRGHRVTVKTTDMSEFEEMRERYPEIPLKILHDDPEEARRLAEEYQKKGLDVTWQP 
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> en2_144244_19_7_0117 
TYEITGGDEEAAKKAEEYWRRGHRVTVKTKDMSEFEEMRERYPEIPLKVLHDDPEEARRIAEEYQKKGLDVTWQP 
> en3_144244_19_7_0381 
TYEITGGDDEAAKKAEEYYRRGHRVTVKTKDMSEFEKMREEYPQITLKILHDDPEEARRLAEEYQKKGLDVTWSP 
> en4_144244_19_7_0442 
TYEITGGDDEAQKKAEEWWRRGHRVTVKTTRMEEFEAARERYPQIPLKILHDDSEEARRLAEEYRKKGLDVTWST 
> en5_144244_19_7_0455 
EYEITGGDEEAAKKAEEYWRRGHTVTVKTTDMSEFEEMRERYPEIRLKILHDDPEEARRLAEEYQKKGLDVTWQP 
> en6_178065_135_428_0354 
TVRLRGRNLAEIVEKLARNGEKVTIEWKGTDESQRKIIEEAIKRAAKHGGELEVEIKVTNEDEQRKMKKWASTADTQVRFKP 
> en7_178065_327_229_0072 
TVHVKGHSEEAERRIKEAIDRNLHVSIEIEGYNEERLRWAMKMAKEAQKKGAPVRVRIKNSDPEKLERARKIIESAGAEVEIT 
> en8_178065_327_229_0254 
TVHVKGNSDEAEERVRRAIKNNQHVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNSNPEELERARKIIESAGAEVEIT 
>en8_-6 
TVHVKGNSDEAEERVRRAIDDDQHVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNDNPEELERARKIIESAGAEVEIT 
> en8_A11V 
TVHVKGNSDEVEERVRRAIKNNQHVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNSNPEELERARKIIESAGAEVEIT 
> en8_S8T_A11V 
TVHVKGNTDEVEERVRRAIKNNQHVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNSNPEELERARKIIESAGAEVEIT 
> en8_re01_S_00000034_wo_angle_cst_0025 
SRMTAKVTQNTPQEEVKKAMDMLRKAAKNNMEVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNSNPEELERARKIIESAGAEV
EIT 
> en8_re02_S_00004588_wo_angle_cst_0019 
KQKQVTVSDSQPPEISKEMAKFVQTAAKQKLSVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNSNPEELERARKIIESAGAEVEI
T 
> en8_re03_S_00017243_0030 
KEVKVTVSKDDPTEKVRKAFEKAKRAASNKYMVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNSNPEELERARKIIESAGAEVE
IT 
> en8_re04_S_00018189_0011 
DRVTVTVSANTQPEHVKTAMDIAAEAAKNKLEVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNSNPEELERARKIIESAGAEVEI
T 
> en8_re04_68C_GGGC 
DRVTVTVSANTQPEHVKTAMDIAAEAAKNKLEVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRCSNPEELERARKIIESAGAEVEI
TGGGC 
> en8_re04_69C_GGGC 
DRVTVTVSANTQPEHVKTAMDIAAEAAKNKLEVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNCNPEELERARKIIESAGAEVE
ITGGGC 
> en8_re04_70C_GGGC 
DRVTVTVSANTQPEHVKTAMDIAAEAAKNKLEVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNSCPEELERARKIIESAGAEVEI
TGGGC 
> en8_re04_88C_82C 
DRVTVTVSANTQPEHVKTAMDIAAEAAKNKLEVKIEIEGYNEQILRDAMRLAKEAQKQGAPVRVEIRNSNPEELERARKIICSAGAECEI
T 
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CHAPTER 3: BOOSTING STABILITY OF Β-SHEET PROTEINS BY SURFACE REDESIGN1 
 
Overview 
β-sheets often have one face packed against the core of the protein and the other facing solvent. 
Mutational studies have indicated that the solvent-facing residues can contribute significantly to protein 
stability, and that the preferred amino acid at each sequence position is dependent on the precise structure 
of the protein backbone and the identity of the neighboring amino acids. This suggests th1at the most 
advantageous methods for designing β-sheet surfaces will be approaches that take into account the 
multiple energetic factors at play including side chain rotamer preferences, van der Waals forces, 
electrostatics, and desolvation effects. Here, we show that the protein design software Rosetta, which 
models these energetic factors, can be used to dramatically increase protein stability by optimizing 
interactions on the surfaces of small β-sheet proteins. Two design variants of the β-sandwich protein from 
tenascin were made with 7 and 14 mutations respectively on its β-sheet surfaces. These changes raised the 
thermal midpoint for unfolding from 45oC to 64oC and 74oC. Additionally, we tested an empirical 
approach based on increasing the number of potential salt bridges on the surfaces of the β-sheets. This 
was not a robust strategy for increasing stability, as three of the four variants tested were unfolded. 
 
 
 
 
 
 
 
                                                      
1 This chapter previously appeared as an article in the Protein Science. The original citation is as follows: D. N. Kim, 
T. M. Jacobs, B. Kuhlman, "Boosting protein stability with the computational design of β-sheet surfaces". Protein 
Sci. 25, 702–710 (2016) (76). 
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Introduction 
Approximately one quarter of all known protein structures are comprised almost exclusively of β-
strands and connecting loops (77). These proteins often adopt β-sandwich or β-barrel folds in which it is 
common for one face of a β-sheet to point towards the hydrophobic core of the protein while the other 
face points towards solvent. As would be expected, the core facing residues play a critical role in 
determining protein stability as they form tight van der Waals and hydrogen bonding interactions with 
other residues in the protein. However, the solvent-facing residues can also play a strong role in dictating 
protein stability, as they frequently form specific interactions with residues from neighboring β-strands as 
well as nearby residues on the same β-strand. For this reason, there has been considerable effort aimed at 
understanding the sequence and structure features that contribute to β-sheet stability (19) (20) (78) (79). 
Mutagenesis studies and statistical analyses of naturally occurring β-sheets have shown that some 
amino acids have a greater intrinsic propensity to adopt β-strands. The β-branched amino acids (Ile, Val, 
and Thr) and aromatic residues are overrepresented in β-strands, while the charged amino acids (Arg, 
Lys, Glu, and Asp) and turn residues (Gly and Pro) are underrepresented. Similar studies have also 
examined the preferences for various amino acids to be placed near each other on adjacent β-strands (80)  
(81). Two of most favored pairings are aromatic pairs and the formation of salt bridges using aspartate or 
glutamate paired with arginine or lysine. These preferences have been used widely to design and stabilize 
model β-hairpins and β-sheets constructed from synthetic peptides (82) (83), but there have been 
relatively few studies that have focused on using these principles for the large-scale redesign of β-sheets 
that are incorporated in folded proteins.  
An important feature of β-sheets in well-folded proteins is that they are fairly rigid, and each 
residue in the sheet has a unique set of phi and psi angles as well as a unique set of neighbors, each with 
distinct geometries that dictate which direction side chains will be projected. An important consequence 
of this variability is that although there are general preferences for particular amino acids and amino acid 
pairs to stabilize β-sheets, the preferred amino acid at a specific residue position depends strongly on the 
precise structure surrounding that residue (81). This complexity and diversity suggests that the most 
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advantageous methods for designing β-sheets will be approaches that take into account the multiple 
factors that contribute to stability including: side chain rotamer preferences, van der Waals interactions, 
hydrogen bonding, desolvation effects, and electrostatics (84). 
Over the last 20 years, methods for computational protein design have emerged as a powerful 
approach for optimizing sequences based on multicomponent energy functions. These protocols have 
been used to stabilize proteins, design new protein structures and interactions, and more recently create  
large macromolecular assemblies (85) (33) (86). In these studies, β-sheet surfaces have been designed in 
the context of larger goals, but there have been few studies that have specifically probed how effective 
these approaches are at designing β-sheet surfaces. For instance, is it possible to dramatically stabilize 
naturally occurring proteins by just redesigning their β-sheet surfaces? Mayo and coworkers optimized an 
energy function for the design of β-sheet surfaces and tested the protocol on the redesign of β-sheets from 
two proteins, in one case there was a modest decrease in protein stability and in the other case the melting 
temperature increased by 8oC (87). In this study, we used the molecular modeling program Rosetta to 
redesign β-sheet surfaces of the fibronectin type III domain of the protein tenascin (TNfn3, pdb code: 
1ten (88). This original TNfn3 structure starts with residue numbers 802R and 803L, while it starts with 
1L in this chapter. Rosetta omits the first Arg residue due to its partial definition. Rosetta’s default 
management of protein structure uses "pose" that rearranges the residue number to start with 1). 
TNfn3 forms a Greek key fold with three β-strands in one sheet and four β-strands in a second 
sheet. It has been studied extensively as a model system for protein folding and stability (89) (90) and 
previous studies have demonstrated that its stability can be improved via mutation. In most cases, the 
stabilizing mutations have been located in the protein core, or the redesigns included a mixture of 
mutations from various regions of the protein (91) (92) (93). 
Unlike the Mayo study, we did not employ an energy function and modeling protocol specifically 
created for β-sheet surfaces, but rather used the all atom energy function in Rosetta, which has been 
parameterized with a diverse set of sequence design and structure prediction tests (94) (95). The primary 
components of the energy function are a damped Lennard-Jones potential that models dispersion forces 
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and steric repulsion, an implicit solvation model that penalizes the burial of polar groups, an orientation-
dependent hydrogen bonding term that has been parameterized to be used with damped Coulomb 
electrostatics, and knowledge-based terms that score dihedral preferences and the intrinsic preferences of 
the amino acids to be in alternative secondary structures. The Coulomb electrostatics term is a more 
recent addition to the Rosetta force field that has been benchmarked computationally (95), but few 
experimental tests have been performed with it. 
In addition to designing β-sheet surfaces with Rosetta, we also tested an empirical approach 
based on increasing the number of salt bridges (glutamate or aspartate paired with lysine or arginine) 
between strands on the surface of the β-sheets. This approach was inspired by previous studies that 
demonstrated that arrays of salt bridges could be used to favor the formation of heterodimeric over 
homodimeric coiled-coils (96). Charge repulsion between like charged groups disfavored homodimers 
while charge attraction favored the heterodimers. A significant challenge in the design of β-sheet proteins 
is how to specify which β-strands will pair with each other. This is especially problematic for tertiary 
folds in which strands distant in primary sequence are paired in the final folded structure. Kinetically, it is 
more straightforward for strands close in primary sequence to pair, and many structure prediction 
algorithms suffer from predicting too many local contacts when performing ab initio structure prediction 
on β-sheet proteins (97). TNfn3 is an excellent example of a protein with a topology that is difficult for 
design and prediction and contains β-strand contacts distant in primary sequence; it includes strand 
pairing between the third and sixth β-strands as well as the second and fifth β-strands. Interestingly, we 
observed that through mutation it is possible to place charged residues on TNfn3 in such a way that every 
β-strand has the opposite charge of the β-strands that are paired with it, and that β-strands that are close in 
primary sequence, but are not paired in the final structure, end up with the same charge (Figure 3.1). We 
reasoned that this arrangement of charges should favor the folding and stability of the protein by creating 
favorable electrostatic interactions in the folded state, while simultaneously disfavoring kinetically 
accessible misfolded states. 
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Figure 3.1 Concept of the charge zipper scheme for the TNfn3 β-sandwich fold. By mutating residues 
on the surface exposed faces of the two β-sheets it is possible to create a scenario where every strand is 
paired with a strand of opposite sign in three-dimensional space, but strands that are close in primary 
sequence, but are not paired, have the same charge. (a) A charge zipper that starts with a negatively 
charged β-strand. (b) A charge zipper that starts with a positively charged β-strand. 
 
Both mutational studies and statistical analyses of β-sheet sequences indicate that there is a strong 
energetic bonus for placing lysines and arginines across from glutamates or aspartates in β-sheets, while 
there is an energetic penalty for placing like charged amino acids near each other (80) (98). However, 
charged residues also have lower intrinsic preferences for adopting β-strands (81) (99) (100). This 
suggests that although charge patterning may stabilize the desired pair interactions, the new charged 
residues may also disfavor β-strand formation. 
 Results 
To test the Rosetta design protocol and energy function on β-sheet surfaces we designed and 
characterized two variants of TNfn3. In the exhaustive simulation, all surface positions on both β-sheets 
of TNfn3 were allowed to vary. This included 18 positions on the four-stranded sheet and 10 positions on 
the three-stranded sheet (Figure 3.2). All amino acids except for cysteine and proline were allowed at 
each position. Interestingly, Rosetta only mutated 5 residues on the four-stranded sheet and mutated 8 
residues on the three-stranded sheet (Figure 3.3). All but one residue on strands 3 and 4, which are in the 
four-stranded sheet, were kept as the wild-type amino acid. We refer to this design as RE, for Rosetta 
exhaustive. The total calculated energy for RE is -195 REUs (Rosetta Energy Units, negative values are 
more favorable) relative to -180 REUs for the wild type protein. The hydrogen bond score is more 
favorable for RE compared to the WT protein (-14 vs. -10 REUs), as well the electrostatics term (-67 vs. -
62; Table 3.1). New interactions predicted to occur in RE include hydrogen bonds between T66 and E68, 
E68 and R70, and D11 with R18. 
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Figure 3.2 Surface exposed β-sheet residues for the various designs. Mutated residues are underlined, 
and the residues which were allowed to vary in the simulations are shown in bold italic. RE (Rosetta 
designed exhaustively), RS (Rosetta designed sparsely), (PE) exhaustively designed charge zipper starting 
with positively charged β-strand, (PS) sparsely designed charge zipper starting with positively charged β-
strand, (NE) exhaustively designed charge zipper starting with negatively charged β-strand, (NS) sparsely 
designed charge zipper starting with negatively charged β-strand. 
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We redesigned sidechains of surface residues with the native backbone of TNfn3, so that the 
redesigned proteins had alternating patterns of positive and negative charges (Figure 3.1) (76). In total, we 
redesigned two control designs (RE, RS), and four charge zipper designs (PE, PS, NE, NS) (Figures 3.2, 
3.3, and Table 3.1). Because the 36th position at WT backbone seriously favors glycine, we kept glycine 
as is. 
 
 
Figure 3.3. Wild type TNfn3 (WT) and redesigns (RE, PE, NE) with surface exposed residues 
displayed in sticks. The top row shows the 3-stranded β -sheet and the bottom row shows the 4-stranded 
b-sheet. The structures are oriented in the same fashion as the illustrations shown in Figure 3.2, in that on 
the 3-stranded sheet G59 is at the top right, and in the 4-stranded sheet residue 88 is at the top right. T86 
and T88 in the WT protein are shown with two alternative conformations as observed in the crystal 
structure. 
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Table 3.1 Computed Stabilities for Proteins.  
 
a Number of salt bridges on the β-sheet surfaces.  
b Total energy for the protein as computed with Rosetta (unit is REU) (101). 
c Coulombic electrostatic potential with a distance-dependent dielectric (unit is REU) (95). 
d Sidechain-sidechain hydrogen bond energy (unit is REU). 
e Lazaridis-Karplus solvation energy (unit is REU). 
f van der Waals (=“Lennard-Jones attractive between atoms in different residues”+“Lennard-Jones repulsive 
between atoms in different residues”; unit is REU). 
g Fibronectin type III domain from tenascin (PDB code: 1ten). 
 
We also performed a design run in which only 8 residues were allowed to vary on the 4-stranded 
sheet and 5 residues on the 3-stranded sheet (Figure 3.2). These residues were picked to emphasize the 
formation of new pair contacts between strands. Residues 44, 36, 68, and 86 were all varied and form a 
line across the 4-stranded β-sheet, similarly with residues 48, 32, 72, and 82. This design simulation 
produced a sequence with 3 mutations on the 4-stranded sheet and 4 mutations on the 3-stranded sheet. 
We refer to this design as RS, for Rosetta sparse. The total calculated energy for RS was -190 REU. As 
with the exhaustive design, there were improved hydrogen bonding and electrostatics energies compared 
to the wild type sequence with scores of -67 and -11 REUs respectively. New interactions included a 
hydrogen bond between E32 and R72, and a tight valine-valine interaction formed between V18 and V57. 
To test the empirical approach of explicitly adding more salt bridges to β-sheet surfaces we 
constructed four variants of TNfn3. In two of the variants we varied most of the residues that were varied 
in the RE (exhaustive) simulation. In one of these cases, we started the charge patterning with the first β-
strand forced to be negatively charged, while in the second case we started with the first β-strand 
positively charged. We refer to these designs as NE, for negative exhaustive, and PE, positive exhaustive. 
In PE, the first, fourth, fifth and sixth β-strands are positively charged, while the other strands are 
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negatively charged. The reverse is true for NE. To pick which charged residues were placed at each 
residue position, we performed a constrained design simulation with Rosetta where residues on the 
positive strands were constrained to lysine or arginine, and residues on the negative strands were 
constrained to be aspartate or glutamate. The final PE and NE designs have 22 and 19 mutations, 
respectively, and were predicted to include 18 and 14 surface salt bridges, respectively. Interestingly, the 
total score for the PE design is more favorable than the score for the NE design, -192 versus -188 REUs. 
One contribution to this difference is that the NE design results in a higher net charge for the protein (-14) 
compared with PE (-5) and wild type (-9; Table 3.2). 
 
Table 3.2 Measured Stabilities for Proteins. 
 
 
 In addition to the charge patterned exhaustive designs, we also created a PS (positive sparse) and 
a NS (negative sparse) design. These simulations used the same charge patterning rules that were used for 
the PE and NE designs. The PS design has 9 mutations relative to wild type and the NS design has 12 
mutations. 
All six of the designs (RE, RS, PE, PS, NE, and NS) along with the wild type protein were 
expressed in E. coli and purified with metal affinity chromatography followed by gel filtration. Circular 
dichroism was used to determine if the proteins were folded. At low concentrations of salt, RE, RS, and 
PE all exhibited a CD spectrum consistent with a folded β-protein, while PS, NE, and NS have CD 
spectra indicative of random coil (Figure 4). The thermal stabilities of the folded proteins were measured 
by monitoring the CD signal at 220 nm as a function of temperature. Both of the Rosetta designed 
sequences were dramatically stabilized relative to the WT protein with thermal unfolding temperatures of 
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74.1oC (RE) and 64.1oC (RS) compared with 45.4oC for the wild type protein. Like the WT protein, the 
designs also refolded when returning to room temperature. These experiments were performed with 0M 
NaCl. At a concentration of 1 M sodium chloride, the designs were also more stable than the wild type 
protein, 58.2oC (WT), 82.2oC (RE), and 77.7oC (RS). Similar increases in stability were observed for RE 
and RS in chemical denaturation experiments with guanidine hydrochloride (Table 3.2). 
 
Figure 3.4 CD spectra and thermal denaturation experiments of the Rosetta designs (panels A and 
C) and the charge zipper designs (panels B and D).  
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Of the charge zipper designs, only PE is folded at low concentrations of salt and has a thermal 
unfolding temperature that is 5oC greater than the wild type protein. Interestingly however, PE is not 
stabilized by salt like the wild type protein, and at 1M NaCl has a thermal stability that is 11oC lower than 
the wild type protein. Intrigued by the dramatic changes in stability with changes in salt concentration, we 
examined NE, NS, and PS to determine if they could be induced to fold by adding salt. NS and NE did 
not fold, but PS was dramatically stabilized with the addition of NaCl. The thermal unfolding temperature 
of PS varied linearly with salt and the protein reached a thermal unfolding temperature of 48oC in 1M 
NaCl and 70oC at 3M NaCl (Figure 3.5). 
 
 
Figure 3.5 Tm measurements for the PS protein as a function of NaCl concentration. 
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Discussion  
Our results demonstrate that protein stability can be dramatically increased by redesigning only 
the solvent exposed face of small β-sheet proteins. Since the Rosetta design protocol aims to optimize 
several energetic features, including van der Waals contacts, intrinsic secondary structure preferences and 
electrostatic interactions, it is not straightforward to assign the increase in stability to any single feature. 
However, it is interesting that like WT TNfn3 both of the Rosetta designs, RE and RS, are stabilized by 
high salt concentrations. This suggests that the stability of these variants is not entirely dependent on the 
formation of salt-bridges between oppositely charged amino acids, as these interactions are predicted to 
become weaker at higher salt concentrations. Consistent with this conclusion, explicitly placing 
oppositely charged amino acids on the surface was not a simple recipe for boosting the stability of TNfn3. 
Three of the four charge zipper designs failed to fold at low salt concentrations. The charge zipper design 
that does fold, PE, is unlike the other TNfn3 variants, in that it is destabilized by high salt concentrations. 
This suggests that the redesign did have the intended effect of making protein stability more dependent on 
surface electrostatic interactions. In contrast to our results with β-sheets, surface salt bridges have been 
shown to have a more dominant role in stabilizing helical proteins (96) (102) (70). This is likely to be in 
part because the charged amino acids, Arg, Lys, Glu, and Asp have a higher intrinsic propensity to be in 
helices compared with β-strands (100). 
One of our goals in testing charge patterning on TNfn3 was our hope that it would provide a way 
to dictate, which β-strands would pair with each other, and in particular destabilize pairing between 
strands that are close in primary sequence but are not intended to be paired. We thought that this would be 
a simple approach to incorporate in the de novo design of β-sandwich proteins, a problem that is still 
unsolved. The results suggest that charge patterning does not provide a simple solution, and indicate that 
the correct strand pairing will need to be specified by the many different structural features that go into 
determining β-sheet stability. 
It is striking that in the design simulation where all residues on the surfaces of the β-sheets were 
allowed to vary, Rosetta only mutated 14 out of 28 residues. This is despite the fact that the design 
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simulation starts from a completely random sequence, and uses a stochastic sampling protocol to find a 
low energy sequence. This suggests that most native residues on the β-sheet surfaces of TNfn3 are 
already optimized for stability, and highlights the fact that every residue in a β-sheet is in a unique 
environment, where the most favorable residue depends on the precise positioning of neighboring 
backbone atoms (103). 
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Materials and Methods  
Computational Design and Analysis of proteins  
We redesigned the β-sheet surfaces on the WT fibronectin type III β-sandwich from tenascin 
(PDB code: 1ten) using the molecular modeling program Rosetta to perform rotamer-based sequence 
optimization in combination with backbone refinement. The protocol iterated five times between the 
PackRotamersMover (rotamer optimization) and the FastRelax protocol (backbone refinement) (18). The 
script used to perform these simulations is provided in the Supporting Information. Residues not allowed 
to change their amino acid identities were allowed to adopt different rotamers (“NATAA”); 1,000–10,000 
independent simulations were performed for each set of design parameters (80–800 cpu hours spent, 
number of design trajectories did not affect greatly the final design selection), and the lowest energy 
sequence for each set was selected for experimental characterization. 
 
Protein Expression and Purification  
All proteins were expressed using a 6-Histidine tagged PQE-80L vector in the BL21* strain of E. 
coli. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was used at 0.4~0.8 OD600 to induce and the proteins 
were expressed overnight at 18oC. Cell pellets were sonicated, and after additional centrifugation, 
supernatant was applied to a Ni-NTA column (GE healthcare). The purified solutions were further 
purified by size exclusion chromatography (GE healthcare HiLoad 16/60 Superdex 75 pg or HiLoad 
16/600 Superdex 200 pg). 
 
Circular Dichroism  
Secondary structure identification and melting temperature measurement were performed using 
circular dichroism with JASCO J-815 CD spectrometer. All measurements were done with 20 μM protein 
concentration. All mean residue ellipticity values shown in this article are CD values of protein sample 
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after extracting CD values of buffer only. Data Integration Time (D.I.T) for ellipticity measurements was 
increased to 8 seconds from 4 seconds especially when high concentration of NaCl was used as buffers. 
When high concentration of NaCl was used as buffers, analysis of full spectrum of the ellipticity was not 
meaningful when wavelength is less than 205 nm. Nonlinear regression (sigmoidal dose-response) was 
used to fit all melting temperatures by Prism software ver. 5.0a (104). Similar thermal unfolding 
temperatures were obtained by fitting the data to the Gibbs Helmholtz equation with nonlinear regression 
by Mathematica 10 (105). 
 
Fluorescence  
All chemical denaturations were evaluated by measuring fluorescence emission spectra (310–400 
nm) with a Fluoromax 3 spectrofluorometer. Similar as in Gilbreth et al. (91), we plotted fluorescence 
intensity vs. [GdnHCl] at wavelength 365 nm after excited at 295 nm. All measurements were performed 
with 5 μM protein concentration at 20 mM sodium phosphate pH 7.0 except PS where the measurement 
was done in 20 mM sodium phosphate pH 7.0 and 100 mM NaCl. 
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[Sequences of studied proteins] 
> WT_1ten 
LDAPSQIEVKDVTDTTALITWFKPLAEIDGIELTYGIKDVPGDRTTIDLTEDENQYSIGNLKPDTEYEVSLISRRGDMSSNPAKETFTT 
> RE 
LDAPQQIRVKDVTDTTARIEWVKPLAEIDGIELTYGIKDVPGDRTTIVLSEDENEYVITNLKPDTTYEVRLRSRRGDMSSNPAVETFTT 
> RS 
LDAPQQIEVKDVTDTTAVITWVKPLAEIDGIELTYGIKDVPGDRTTIVLTEDENQYVIGNLKPDTEYEVSLRSRRGDMSSNPAKEYFTT 
>NE_NATAA_keep_36G_1ten_chain_A_res-renum_starting_w_2L_res-renum_0951 (lowest energy --> -1.78 REU) 
LDAPEQIEVDDVTDTKARIKWKKPLAEIDRIRLRYGIKDVPGDDTEIDLDEDENEYEIENLKPDTEYEVELESERGDMSSNPAKERFTT 
>NS_NATAA_keep_36G_1ten_chain_A_res-renum_starting_w_2L_res-renum_01847 
LDAPEQIEVKDVTDTKALIRWRKPLAEIDRIELRYGIKDVPGDRTEIDLDEDENEYSIENLKPDTEYEVELISERGDMSSNPAKETFTT 
>PE_NATAA_keep_36G_1ten_chain_A_res-renum_starting_w_2L_res-renum_0671 
LDAPRQIRVKDVTDTTAEIEWEKPLAEIDEIELEYGIEDVPGDRTRIRLREDENKYRIKNLKPDTRYRVRLRSRRGDMSSNDAEEEFET 
>PS_NATAA_keep_36G_1ten_chain_A_res-renum_starting_w_2L_res-renum_0646 
LDAPKQIEVKDVTDTTAEITWEKPLAEIDGIELTYGIKDVPGDRTTIKLTEDENQYRIGNLKPDTEYRVSLRSRRGDMSSNEAKEDFTT 
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CHAPTER 4: DE NOVO DESIGN EFFORTS FOR B SANDWICH PROTEINS 
Introduction 
Despite the significant prevalence of all-β proteins (23% of all known structures (77)), the 
mechanism of folding is not well understood (106). This is especially true with regard to β-sandwich 
proteins, which constitute the highest percentage of domains among the mainly β-class (107), and are 
often found in various immune systems including antibodies (Figure 4.1). Among the β-sandwich 
proteins, we used the fibronectin type III domain of the protein tenascin (TNfn3), because, interestingly, it 
has a complex Greek-key motif (Figure 4.2). Unlike simple β-meanders and α-helices, this Greek-key 
motif protein has high contact orders. This means that this motif has many residues that are distant to each 
other in primary sequence, but near each other in 3-D space. This high contact order makes this protein a 
more challenging target to study protein folding (108)(109)(110).  
 
Figure 4.1 β-sandwiches (identified in blobs) in various immune systems (111).  
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Figure 4.2 Overall Greek-key motif topology of fn3 β–sandwich   
 
The fibronectin fold, as an extracellular matrix protein, has many biological implications also 
because it is crucial for cell adhesion, growth, and survival during embryogenesis, wound healing, and 
maintenance of normal tissue architecture (112) (113) (114). Because of these biological implications, 
there has been much research on folding and unfolding of this fibronectin fold (115) (116) (89) (117) 
(118) (119) (120). In order to better understand structural features and to engineer for various 
applications, attempts have been made to design this fold de novo for more than a decade (121).  
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Computational Design and Experimental Results 
De novo design of β-sandwich proteins has been elusive a goal. For example, 22 designs by 
Xiaozhen Hu did not show design success (121). We thought that one of the main reasons of these 
failures was backbone design problem, because we could successfully redesign sidechains with a native 
β-sandwich backbone (57). Therefore, we tried to design backbones with three alternative approaches to 
best sample ideal backbones: backbone design by SEWING, backbone design by assembling β-strands 
with randomly perturbed backbone torsion angles, and backbone design by ab initio folding. 
 
Design of Backbone by SEWING 
We designed Greek-key motif β-sandwich backbones by SEWING (for all-β-sheet proteins, we 
assembled bundles of four β-strands). What we had aspired to achieve was intricate “ideal” native 
distances and angles among native β-strands that are not easily captured (Figure 4.3) (122). However, 
unlike α-helices (surveyed by Timothy Jacobs), there were not enough bundles of four β-strands for the 
assembly. This is largely because β-sheet structures are curved compared to α-helices. 
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a)  
b)  
Figure 4.3 β-sandwich backbone design by SEWING. a) overall concept, b) initial results. Top 8,000 is 
a collection of high quality protein crystal structures (123). 1ten is the pdb code. Native strand means 
each β-strand is used one time for assembly. Partial strand means each β-strand can be used multiple 
times because each strand is partially used. 6 res means 6 residues are used for assembly. 
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Design of Backbone by Assembling β-Strands with Random Backbone Angles  
We generated five β-sandwich designs (S1~5 which stand for small) by assembling backbones of 
randomly perturbed backbone torsion angles using a PyRosetta utility (written by Brian Kuhlman). What 
we tried to achieve was better sampling of possible “designable” backbone conformations 
computationally. However, S3 was expressed as a soluble aggregate, and the other 4 designs were found 
in pellets (sequences of these designs are in supporting materials). Because many of them did not bind to 
Congo Red, these designs may not have formed patterned amyloid fibrils. These designs seemed 
completely unfolded because they did not bind to 1-anilino-8-naphthalene sulfonate (ANS). Therefore, 
known explicit negative designs may not have rescued these designs (124).  
 
Design of Backbone by ab initio Folding  
Three β-sandwich designs (L1~3 stands for large) were generated by traditional ab initio folding 
(33) (42). This method folds a linear polypeptide chain with pre-extracted backbone torsion angles.  
When it folds, it replaces current backbone torsion angles with these pre-extracted ones for either 3 or 9 
residues long. Therefore, it often is referred as fragment insertion. To achieve our desired β-sandwich 
topology, we applied various geometrical constraints during the folding simulation. However, L1 was 
expressed as a soluble aggregate, and the remaining two designs were found in pellets as well (sequences 
are in supporting materials). I expected that these L1~3 designs might have folded, because larger 
backbones tend to be more stable (60) (61). However, because these designs were larger than previous 
designs (S1~5), these designs would have been more difficult to computationally refold.  
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Design with Folding Nucleus Conservation  
Three β-sandwich designs (C1, C3, C4 which stand for conserved) were created by imitating a 
known folding nucleus. Although this is not a pure de novo approach, the known folding nucleus is highly 
conserved (125). Rosetta mutated known tyrosine corner into a phenylalanine. We used Rosetta chosen 
ones although we knew that phenylalanine is known to compromise some stability (126). Another highly 
conserved tryptophan was kept. However, all designed proteins were expressed as soluble aggregates 
(sequences are in supporting materials). 
 
Design with Repopulation of Existing Backbones  
We generated eight β-sandwich designs (R1~8 which stand for repopulated) via repopulating 
fragments of a native β-sandwich protein (pdb code: 1L9N). Although this is not longer a pure de novo 
design approach, we hypothesized that it might sample backbone conformations more effectively. 
Furthermore, we improved sidechain packing in our designs through cartesian minimization (127) (Figure 
4.4). However, all designed proteins were found in pellets (sequences are in supporting materials). 
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Figure 4.4 Packing comparison of various WT β-sandwich and design tried ones. The ones in green 
box shows R1~8. “WT” β-sandwich protein with 0.7 hole is redesigned β-sandwich protein (pdb code: 
3b83). WT β-sandwich protein with 2.8 hole is the NMR determined structure (pdb code: 1k85). Rosetta 
hole calculation algorithm tends to give poor score to NMR derived structures.  
 
Redesign with Native β-sandwich Backbones  
Although we had succeeded a redesign with native β-sandwich protein, our 19 de novo design of 
β-sandwich proteins fell short. Therefore, we wanted to determine whether a current general purpose 
Rosetta score function could reliably redesign native β-sandwich proteins. In total, we redesigned 14 
designs (re1~7 and re9~15, which stand for redesign) and expressed them (Table 4.1) (sequences are in 
supporting materials). Except a fixed design of 1yq2 (re05), most designs were either aggregated or not 
expressed. Therefore, it seems obvious that we may need to use used β-sheet optimized score function as 
before (128). This conclusion was made with various supporting factors: all used genes were codon-
optimized, most non-expressing designs were tried to be induced at both 18oC and 37oC and 50ml and 1.5 
L LB media cultures, and this is a large-scale test (we used 7 native backbones, if we include one more 
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native backbone, it would be 8 backbones in total, the native backbone that we excluded came from pdb 
code 3hn3, this protein was expressed by Mus musculus before, when we tried to express extracted β-
sandwich proteins after fixed backbone redesign and flexible backbone redesign, both redesigns were not 
expressed in E. coli, however we excluded for analysis because there was not guarantee that even WT 
protein is expressed by bacterial system). 
 
 
Original pdb 
file Backbone Name MW (kDa) Conserved Y RMSD (Å) 
Sequence 
recovery (%) Expression 
1ten 
WT 1ten  yes 0 100 WT 
fixed re01 12.4 yes 0 37 No expression 
flexible re09 12.2 yes 1.0 28 No expression 
2r2c 
WT 2r2c  yes 0 100 WT 
fixed re02 14.6 yes 0 32 Aggregate 
flexible re10 14.4 no (F) 1.2 29 No expression 
1bgl 
WT 1bgl  no 0 100 WT 
fixed re03 14.5 no 0 25 Aggregate 
flexible re11 14.2 no 1.4 20 Aggregate 
1fnf 
WT 1fnf  yes 0 100 WT 
fixed re04 13.3 yes 0 38 Aggregate 
flexible re12 13.0 yes 0.8 35 Aggregate 
1yq2 
WT 1yq2  no 0 100 WT 
fixed re05 14.4 no 0 38 β-sheet 
flexible re13 14.8 no 0.9 39 No expression 
3r8q 
WT 3r8q  yes 0 100 WT 
fixed re06 14.0 no (F) 0 37 Aggregate 
flexible re15 13.0 no (H) 1.1 30 No expression 
3tes 
WT 3tes  yes 0 100 WT 
fixed re07 12.6 yes 0 43 Retry needed 
flexible re16 12.7 yes 0.7 30 No expression 
 
 
Table 4.1 Redesign with Native β-sandwich Backbones. 
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Conclusion 
It has been very challenging to design all β-sheet proteins de novo (32). Our 22 designs by 
Xiaozhen Hu and 19 designs by Doo Nam Kim were all not successfully folded (121). These failures 
were somewhat unexpected because all these designs (including Xiaozhen Hu’s 22 designs) had pretty 
good Rosetta total scores when calculated with the original “score 12” score function “score 12” (33) with 
explicit electrostatic terms. Evidently, the Rosetta total score alone is not enough to predict well designed 
β-sandwich proteins. 
Supporting Materials  
> S1 
MTAGGTHKNGKFFVDVHGKGNVDVDVEIRAGNVRRRYRVIGGPGERIEFQGDTAGEARVYVRDGTWEQTLYLK 
> S2  
MRVEIRMDNGWVRVDAEGDGPFKVDAQSRGGGYDYQVRTELVGRREITVQGAPNGEVRVRLRENGEEREFQYK 
> S3 
MRFRGTRKGNYVEVEAKGDGTGNYEIKAKGGGQEYRYRAPTYGGSSWRGKIYPGGTFRVEVRIGNLNTEGEFK 
> S4 
MEYEIRVDNGEYVFRVGNSHRPEGEVRVFYNGIHIQKGTKYGDGQKIRVRGYLNGQVHFRFGGDNEDYEIVLG 
> S5 
MELRFELTGDYGRGFLRGYGYAELGFYVIFNGDETGFTTGGYGGQEFKFQGYPTGRYRLIARSGGEELRYEYE 
> L1 
MVEGRMEVRIHNGRAIGYGYVWSKTNPQKLRWRGVIVAGGVGAEFETGSDDDGTSLTVTVDTKGKTGVIRGRGEARGQKNGQEFRS
EVEMTPD 
> L2 
MSEARAEIGVHNGRLRVRVYGRSDSQGQENRMRGYMIVGGYRYETTGDGPPGATGFDIEVEHEGREGQAHFRGKVRGNINGDEQEYE
TQYGSL 
> L3 
MAQLQTGYHWRNGHLGGLVRIIDNGAGGRGYVEIYVRGGNVDYKLQTEFPENGSHVEAEVHGEGNTKDFKVFARAVFYINGVEYRF
EIRDGAG 
> C1 
PTTGRVSVQVQGNAVTVEWQGGDSVTRITLRFTDGDGNPTSLTVEADGNGDRRITVPVPSGSFTIEITVESGTGTTLTQTVDLAG 
> C3 
DSSSRVSATENGPAMTVTWTGTRDISRITVTFTDGGGTGTKVTLEVTGNGDTSVTVPVEGGRFKVTIRLEESNGTTDELEVDGSQ 
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> C4 
PEPTQVTITRTGDNVTVTWTGEEEIREVTLTFTDARGQDSKRTVSAVGETVTTVTIPVPLDQYRVTVSLESKNGTTLTLTIDASG 
> R1 
PPIVRLELDQTIIPGLPILFTARIQNHQPTVLKNIRIEFLEQPDPKITHEYVVGPLRPGEEVVIQFLHLPPTTGTLTIIWNYILPGTTTIVVTMT
LTI 
> R2 
TETLVVTVEPNPEPGKEFRVEIRVTNLTNLPWRNIRVEIRLPGHITVPIEIIFTTLPPGQTIVIETSHIPTTRGTITFELRVETEPQTDIETSYNL
TI 
> R3 
IPTLILTVEPNIEPGKEFTVTVIVTNLTNLPWRNIEVNILLPGHIDVPITIIFTHLPPGQTIVITTSIIPRTTGTLEFQLEVNTEPQTDIRTSYTLTI 
> R4 
THLFTIDIPGVPEPGKPHLIRVTFINLSNTKHEGGTVNVEIPGLHTGRITVTFEPRPPGQTHTYPLILIPQQTGRITILFELHTSTQRHIEFRLD
TVL 
> R5 
TVELELILVNPHTEGETFILTLRFTNKTPVPVPNVQAEWWKTLTRTETQTYQIPTITPGETVNVKVEVTIPTRGVTTFEYRMTAELQPEEV
RQTVMSD 
> R6 
TPTLDLQLITQSVPGTTFILELRITNLTNVPLRGLHVELLVPPHLTTPLSWQPKPSTPGEVVEWVQEFLLKTTGTFTLIYNWRHETLPVLTH
TRTMTH 
> R7 
PSNIRLQTLTTLVPGQNWRFEVLYQNSSTTVLVNIRVEIEFKNQPGRTVVIQTRPLTPGELLSLVFEIHIPHPGTLVWEIRVEAKGFTLETQ
QHTLVV 
> R8 
PDPLRLQLLVPIELGKTVIWELRFTNLQPTVLTNIRLEIRIENQTGLPREQVYPPLPPGQTMIFTIIYTITVPGTTRLELHVEAPGVPTLVVSQ
TTIT 
> re1_1_1_1TEN_A_0001_VAL_0967 
LESAQNIQVIKITKTTAVVIFLPSTDPVQGYEMTYGYKEDPSDRVTVVLTSSIDHYVITNLKPNAVYIVRIVARNGDLKSDSTARTYKT 
> re2_1_1_2R2C_B_0001_VAL_0848 
TKVLVFAEARWIGKNYIEIRAIGQVLPGYTVSPAFMRVLLLMLWEVQSFVNGDLGDYFVPGKVYVYTHEVNPPEGAPLDQNKYAVKV
EIYSSQTGEVYAEIVVSIKPPG 
> re3_1_2_1BGL_A_0001_VAL_0334 
PSLFDTYLDGQILIVRSNSDTSESRNYVLRGRQALNGVVLSTSEVRAHATARGEQYVVTSTLTNTTDPGEVWLEYRFYQEQPTDTSPGG
AEMGNSKFKYAQVDKYYSG 
> re4_1_2_1FNF_A_0001_VAL_0160 
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GDTESPTNIVFTNIGPDRVEVRWKPPPNRDLSGFDVRWHHRNHKEKAYRQEVSPTLYYIILTNLKPNGEYVVGVAAREGTADSDEARG
TVRTGKAPG 
> re5_1_2_1YQ2_A_0001_VAL_0537 
PASIELHLTYPPGGRVVLEVRNNSTKSDASMFLLFYRVMINGVVATYGVKEARGSNGALSAGEATKIELPPFPPSSTGKTVVEVVAKWK
LAGPTWPSGQPEGYTKLDMSASQG 
> re7_3R8Q_sandwich_1.clean_0001_VAL_0651 
TQEAPRNLTTLEVGPHYLVIKWEPPPTQLGGFEVRVEPALKLGKAFNVWLPPNASSAVITGLLPNTEFEVRVFAVNGPEYSSPATAVVV
TKAPSG 
> re8_3TES_A_res-renum_0001_VAL_0819 
LEGPRNLRATNVTKKSIELRWEAAPNQFRAFVIEWEEARRRGTAYRHEVHGSQRTYLLTGLLPNTTYEVAIQGRLNGQDSAPHSAYFTT 
> re9_1_1_1TEN_A_0001_VAL_0470 
LKPAQNVHVTNTTSHTALVLWDASDDQVQGYLVMYGKADDSSDRVIGFASANDRYWLITNLEPGARYEVVVIAINGNLHSDGNSTTF
VA 
> re10_1_1_2R2C_B_0001_VAL_0599 
PVIEIQAWARWVGPKYIEVRVTVRTAPGYTVPEATVEVWLVTGGGVRAPVNGTDGQPAITGQTWVFYYQVEPEPGYTLDQSKFAINA
RVASAHTGQVWAEQVVPIEPQG 
> re11_1_2_1BGL_A_0001_VAL_0967 
RSYYETRLDGRVILGISKADTDDSTNAVVEVHAHNNGLTLYTGRYPANAPAGGAERVVLDQIKETTAAGEIWIEVYFRAKTAGDNYPA
GYIKGYGKHKFSEVPDNVSG 
> re12_1_2_1FNF_A_0001_VAL_0067 
PPTLSPTDGRFTDVSARAVRVEWRPPDNLDARGFIVVYFKKNDKSDMYVAVVPSSSTYYIATNLEPGAEYVFRVAALLGTSISDSLEGT
QQTGLEPG 
> re13_1_2_1YQ2_A_0001_VAL_0226 
PAEIQLHLTFPPGGKVLLLVINNSDTSDASLFVLYYRVMDNGDVKRYGVKEARGSNGPLTAGETSVQVLEPFPPQPTGKTVVEVIARFK
VTTSRAPSGYPHGYTRLDATLEQK 
> re14_1_2_3HN3_A_0001_VAL_0203 
GTFVAAVYVWTTQRGTISVVRFLIVVLGSQDYRIVVIIRDSNGQPQGGSSGSTGEAKVPNGKFAQPTGQHKYAHIYHYMEVILYARTDN
GWEMYIYIQTVPSTG 
> re15_3R8Q_sandwich_1.clean_0001_VAL_0170 
TEIPPQNLTVLEIGPHYTVIWFIAPPTQLTGFKVIVTAKEDRGTSLVVWQHATSNYAVITGMLPNTTHEVRVIAVNGPEYSSPAKHYVTT
KEESR 
 
 75 
CHAPTER 5: FUTURE DIRECTIONS 
Towards More Efficient Protein Design 
After about three months, I chose what I thought were the best eight designs for the first round of 
de novo designs of β-sandwich proteins. Because I heard that a more senior member of my lab (Ben 
Stranges), had tried a lot of experiments for his designs, I wanted to save valuable experiment time by 
only trying the best designs. Consequently, I lost some valuable opportunity to gain feedback from 
experiments. It turned out that lessons learned from experimental validation were more important than the 
somewhat uncertain computational design methodology improvements. I learned that as long as a 
computational design methodology improvement is not that significant, fast experimental validation is 
very efficient in the long run.  
Also, I spent too much time trying to express and purify less promising designs such as S3, en4, 
and en6 proteins. Overall, I tried to express about 90 designed or WT proteins about 200 times, many 
proteins were tested multiple times with alternate expression and purification protocols. The rationale for 
these multiple tries was to confirm experimental validation or to find better ideal expression or 
purification conditions by repeating experiments in slightly different methods. However, the verdicts were 
eventually that these less-promising proteins were indeed either aggregated or were expressed not enough. 
Most of the time, when the expression yield or purification was not good (“not well behaving proteins”) 
the first time, additional trials were also fruitless. If I were to do Ph.D. training again, I would try to 
express or purify one or two times at the most. I hope that any protein designer who reads this article will 
design proteins much more efficiently based on my experiences. Also, sometimes using a concept or 
method from another field can be effective (129). For example, a statistical analysis borrowed from the 
stock market helped protein sequence analysis (130). Because the computational protein design field is 
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rapidly evolving especially among the Rosetta community, effective mutual learning and teaching from 
other protein designers is absolutely critical. 
Necessity of Experimentally Determined Structural Information 
Most computational protein design methodology developments are iterations between 
computational design and experimental validation. It is critical to get experimental validation results, 
because they guide the next step during design methodology developments. In particular, experimental 
structural information is very important because we design protein structures. However, x-ray 
crystallography was challenging for us because crystals were not formed. Furthermore, 3D structure 
determination using NMR was difficult because the target protein (“en8”) was a homo-dimer. In the near 
future, the iteration between design and structure determination will be greatly facilitated because of cryo 
EM, which does not need protein crystallization and can elucidate atomic resolutions (Figure 5.1). 
Scientists have been pushing the lower size-limit and resolution of biological molecules by cryo EM; as 
of 2016, cryo EM can decipher structure of protein as small as 130 kDa and as accurate as 1.8 Å 
resolution (131) (132) (133). 
 
Figure 5.1 An example of using Phenix real-space refinement to refine atomic models into 
cryo-EM maps (134). 
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Towards a More Accurate Score Function 
A score function is absolutely critical for higher success rates of computational protein design and 
folding (135). In fact, according to the random energy model, unfolded state energies are dependent only 
on amino acid composition rather than the specific arrangement of amino acids. Therefore, energy 
discrepancies between computational predictions and experimental results are due to force field flaws that 
account for folded state sequence energies (136).  
For a more accurate score function, we need to pay more attention to reflect local properties 
instead of trying to achieve higher sequence and rotamer recovery rates with a global model. However, 
most of the recent Rosetta score function developments were done with monomer structures for a global 
model (94) (95). Therefore, even the latest score function (“talaris_2014”) cannot exceed sequence 
recovery higher than 50%. Of course, I believe that no matter how much the Rosetta community strives to 
improve the sequence recovery rate with energy terms, we cannot reach 100% because nature seems to 
consider non-energetic factors such as aggregation prevention keepers and functional moieties. To truly 
reflect these complex native sequence properties, the score functions need to be applied differently 
according to relative location (surface, intermediate, and core). The score functions also need to be 
applied differently according to biological target (membrane proteins or exposed ones). These score 
functions also need to be applied differently according to secondary structure (helix, loop, and edge β-
strand and core β-strand). For example, when I counted occurrences of amino acids according to relative 
orientation and locations of 203 WT β-sandwich proteins that have less than 120 residues, there were 
strong dependences on relative orientation (Figure 5.2).  
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Figure 5.2 Distribution of amino acids in WT β-sandwich proteins. 
 
Indeed, electrostatic interactions are more often found at protein-protein interfaces, and explicit 
consideration of these interactions often brings successful protein designs (28) (29) (30) (31). I also 
observed minor dependence of amino acid distribution on relative location. This difference may have 
arisen from a negative design perspective to prevent unwanted aggregation (124). To better reflect local 
properties rather than relying on a global monomer model, one needs to use different training sets 
according to relative location (interface, surface, and core), biological target (membrane or exposed 
proteins), and secondary structure (helix, loop, and sheet) when fitting coefficients using optE (137). Of 
course, for real application of these score functions, Rosetta will apply different score functions 
depending on local environments. 
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Current Rosetta score functions have linear coefficients. Therefore, in certain cases, the 
interpretation of score functions regarding the energy term that specifically affects the observed outcome 
might seem straightforward. However, there are many score terms that are often redundant to each other 
due to their inherent properties of being knowledge base potential and molecular mechanics force fields 
(138). I need to confirm this claim by analyzing standard beta values using JMP statistical software. 
However, the fact that there are around 17 score terms (that some of them are dependent on each other) 
for a single score function, even after preliminary trials of reducing redundancies, is a strong indication 
that there are still significant redundancies among the score terms. Therefore, the interpretation of current 
score functions may not always be straightforward. Consequently, according to my machine learning 
experiences, the optimization of score terms’ coefficients using neural network (to maximize sequence 
recovery rate) rather than linear regression appears to be a better choice.  
 
Towards Successful De novo Design of β-sandwich proteins 
De novo design of all β-sandwich proteins remains as one of the most difficult goals. Thorough 
analysis of native β-sandwich proteins by SandwichFeatures (139) shows that my eleven de novo designs 
(designed using: backbone assembly, ab initio folding, and conserving folding nucleus) have comparable 
geometric features with respect to: amino acid distribution, backbone dihedrals (ramachandran), β-sheet 
capping, buried unsatisfied H-bonds, chirality of sidechains, distance between facing β-sheets, 
electrostatic interactions, exposed hydrophobic areas, high contact order of backbone (folding order), 
interface area between facing β-sheets, length of components, native-like local structure (fragments), 
negative design to prevent aggregation, net charge, ratio of sheet/loop, right-handedness, and β-sheet 
shape. However, these eleven designs pack more poorly than native β-sandwich proteins. My newer eight 
proteins designed de novo (by repopulating existing backbone fragments and cartesian minimization) 
have all the native geometric features mentioned above in addition to packing comparatively to native 
proteins (R1~8, Figure 4.1). However, these designs still expressed in aggregated form. The factors that 
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we miss for successful beta-sandwich design may be understood from scientific analysis of conserved 
residues as in Poreski et al. (140). Many of these conserved residues seem to be critical for folding 
perhaps as a folding nucleus (117) that may not be easily captured by the rosetta score function. 
As fourteen redesign tests (with seven native β-sandwich backbones in chapter 4) and our 
previous redesign of β-sandwich protein success (128) have shown, successful future design may need to 
use the β-sheet optimized score function (87). Indeed, when Xiaozhen et al. previously redesigned a WT 
β-sandwich protein with a β-sheet optimized score function (128), the sequence recovery was 42%. 
However, when I used a regular score function for redesigning WT β-sandwich proteins, the average 
sequence recovery was 36% (minimum 25% ~ maximum 43%) for fixed backbone design and 30% 
(minimum 20% ~ maximum 39%) for flexible backbone design (of course, the sequence recovery rate for 
the flexible backbone design is to some extent hypothetical).  
In addition to this beta-sheet optimized score function, if we design batter packed protein 
structures and improve poorly performing Rosetta samplings for high contact order proteins (110) and 
secondary structure prediction algorithms (109) for important forward folding trials (43), we may finally 
successfully design β-sandwich proteins de novo. Because forward folding for the full structure of beta-
sheet structure is challenging, prediction of loop structure will only be a viable solution for now (74). I 
believe that charge zipping (chapter 3) of beta-sheet proteins will likely increase the success rate by 
inducing desired folding order (because there are many possible folding orders in Greek key motif 
proteins (141) ). Furthermore, the ideal electrostatic interaction seems to improve thermal stability (140). 
Of course, our charge zipper designs (chapter 3) did not fold as we expected. These failures may be 
rescued by modifying reference values of charged residues as supercharging protocol did (19) (20) instead 
of forcing charged residues by resfile. As PE and PS folded while NE and NS did not fold, the 16th 
threonine may have to be kept as native. In addition to these computational methods, quick experimental 
validation of designed proteins’ stabilities may be a viable alternative until computational based design 
method mature (142). 
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Potential Applications of Designed Proteins 
At times, basic research seems to lack application in the near future such as the knowledge based 
Rosetta score function (“score12”) that was used for de novo design of α/β protein, top7 (33). However, 
often times, long term practical applications are readily visible including designing a pH-sensitive IgG 
binding protein, an enzyme of a novel metabolic pathway, and influenza binding proteins (10) (12) (13). 
Likewise, newly discovered linear correlations between NaCl concentration and protein stability (chapter 
3) may open many new protein-engineering goals such as the delivery of molecules according to salt 
concentrations, as the NaCl is often linked to many diseases (143). Once we attach a fluorophore to our 
fnIII β-sandwich protein, we may be able to easily visualize NaCl concentrations in our body in real time, 
similar to fluorophore–labeled antibodies targeting the antigen (Figure 5.3). If we engineer fnIII β-
sandwich proteins’ loop regions to bind to certain targets, these β-sandwich proteins will bind to targets 
according to NaCl concentration and local temperature as well (144). 
 
 
 
Figure 5.3 Molecular imaging of a mouse implanted with tumors that bear a specific antigen (145). 
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De novo designed α/β protein (en8) may be a useful scaffold because αβ class proteins tend to 
have longer half-life than α and β class protein (146). Furthermore, the en8 protein has N and C-terminal 
residues that are located at the edges in 3-D spaces, which are expected to fold and unfold faster (147). 
Reasonably high melting temperature of the en8 (higher than 65oC) is encouraging because often proteins 
tend to be stable when they are large or have N and C-terminals that are located in the middle (63). The 
faster folding and unfolding rates may allow these proteins to serve as nucleic acid binding proteins where 
frequent binding and unbinding are desired rather than super tight binding. Indeed, nuclear complex 
proteins that act on DNA and RNA tend to be highly dynamic engaging in transient interactions with each 
other (67). In order to verify this hypothesis, folding and unfolding rate measurements may be necessary. 
 
 
 
Possible Reason of Increased Expression Yield of High Net Charged Proteins 
Although some supercharged (high net charged) proteins (β barrel and β sandwich) tend to 
express lower yields (19) (20), my supercharged designs (chapter 2) expressed more than the original 
designs. This difference in expression yield may be explained by a difference in supercharging magnitude 
and protein fold. The reason that my supercharged α/β, α+β proteins expressed more than their original 
designs could be explained by less favorable intermolecular interactions between monomers due to higher 
net charges. This explanation is very similar to glycosylation in nature. Glycosylation, the most prevalent 
post-translational modification of proteins, tends to make proteins more soluble. However, because water 
molecules interact more favorably with peptides rather than with glycans, promoted solubility by glycans 
seems to come more from steric inhibition of protein-protein contacts than from favorable solvent 
interaction with glycans (148). 
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APPENDING CHAPTER: USED ROSETTA INPUT PROTOCOLS 
Rationale 
Inspired by previous peptide design cases (149) (150), I’ve iterated “FastRelax” (for backbone 
conformation perturbation) and PackRotamers (for sidechain design) for both charge zipper designs 
(chapter 3) and for most of the de novo designs for β-sandwich proteins (chapter 4). However, instead of 
simple iteration between “FastRelax” and PackRotamers, “FastRelax” alone, which allows sequence 
design as repulsive weight is ramped up gradually, does the very similar job of flexible backbone design 
along with sequence design and seemed to better pack residues (101). This new method is essentially 
same with the “FastDesign” protocol in Rosetta software suite, which has more on-the-fly filters. I’ve 
used “FastRelax” with sequence design option for α/β and α+β de novo designs using SEWING (chapter 
2) (151).  
Here I present my last example of Rosetta scripts (152), a corresponding flag and resfile. Filters 
such as score_norm and SecondaryStructureHasResidue are fairly useful in eliminating the need of later 
processing by perl or python.  
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RosettaScripts 
<ROSETTASCRIPTS> 
        <TASKOPERATIONS> 
            <RestrictToRepacking name=restrict/> Only allow residues to repack. No design. 
            <IncludeCurrent name=keep_curr/> 
            Includes current rotamers (eg - from input pdb) in the rotamer set. These rotamers will be lost after a packing run, so they are only 
effective upon initial loading of a pdb! 
 
            <LayerDesign name=layerdesign make_pymol_script=1 layer=core_boundary_surface_Nterm_Cterm use_sidechain_neighbors=1> 
              <core> 
                <all append="AFGILMNPQVWYHKRST" /> 
                <all exclude="CDE" /> 
              </core> 
 
             <boundary> 
               <all append="AFGILMNPQVWYDEHKRST" /> 
               <all exclude="C" /> 
             </boundary> 
 
             <surface> 
              <all append="AGMNPQDEHKRST" /> 
              <all exclude="CILVFWY" /> 
             </surface> 
 
            </LayerDesign> 
 
            <ReadResfile name=resfile filename=min_resfile.txt/> 
        </TASKOPERATIONS> 
        <SCOREFXNS> 
<talaris2014_cart weights=talaris2014_cart> 
             Reweight scoretype=coordinate_constraint weight=1/> 
             Reweight scoretype=res_type_constraint weight=1/> 
</talaris2014_cart> 
<cen_score weights=score3/> needed for env 
        </SCOREFXNS> 
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        <FILTERS> 
<ScoreType name=env scorefxn=cen_score score_type=env threshold=10000/> 
           <ScoreType name=total_score scorefxn=talaris2014_cart score_type="total_score" threshold="0" confidence="0" /> 
<Rmsd name=rmsd threshold=999999999 superimpose=1 superimpose_on_all=1> 
 </Rmsd> 
<NetCharge name=charge/> 
<Holes name=holes threshold=15 /> 
<Time name=time/> 
<ResidueCount name=percentage_of_ala max_residue_count=10000 residue_types="ALA" count_as_percentage=1/> 
<ResidueCount name=per_DE max_residue_count=100 residue_types="ASP,GLU" count_as_percentage=1/> 
<ResidueCount name=per_RK max_residue_count=100 residue_types="ARG,LYS" count_as_percentage=1/> 
<ResidueCount name=per_ST max_residue_count=100 residue_types="SER,THR" count_as_percentage=1/> 
           <ResidueCount name=per_FWY max_residue_count=100 residue_types="PHE,TRP,TYR" count_as_percentage=1/> 
       <SecondaryStructure name=ss 
ss=hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh/> 
      <SecondaryStructureHasResidue name=must_have_core_res nres_required_per_secstruct=2/> 
 <BuriedUnsatHbonds2 name=bunsat 
            scorefxn=talaris2014_cart 
            jump_number=0 
            cutoff=20 
            generous_hbonds=true 
            sasa_burial_cutoff=0.01 
            AHD_cutoff=90 
            dist_cutoff=3.0 
            hxl_dist_cutoff=3.5 
            sulph_dist_cutoff=3.3 
            metal_dist_cutoff=2.7 /> 
           <ExposedHydrophobics name=exposed/> 
<ResidueCount name="nres" confidence="0" /> 
<PackStat name="packstat" threshold=0 chain=0 repeats=1 /> 
<CalculatorFilter name=score_norm confidence="0" equation="SCORE/NRES" threshold="3" > 
<SCORE name="SCORE" filter_name=total_score /> 
<NRES name="NRES" filter_name="nres" /> 
</CalculatorFilter> 
<SSPrediction name="sspred" threshold=1 use_probability=true use_svm=true /> 
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 <SSShapeComplementarity name="ss_sc" verbose="1" loops="1" helices="1" /> 
 <CavityVolume name="cav_vol" /> 
 
############### fragment assessment ############## 
<FragmentLookupFilter name="faulty_fragments" lookup_name="source_fragments_4_mer" 
store_path="/nas02/home/k/i/kimdn/db/many/vall/VALL_clustered/backbone_profiler_database_06032014" lookup_mode="first" chain="1" 
threshold="50" confidence="1" /> 
</FILTERS> 
 <MOVERS> 
<SwitchResidueTypeSetMover name=to_fa set=fa_standard/> 
<AssemblyConstraintsMover name=ACM native_rotamers_file=278711_5_1.rot native_bonus=1 native_pro_bonus=2/> 
<FastRelax name=fastrelax repeats=1 disable_design=false scorefxn=talaris2014_cart cartesian=1 
task_operations=resfile,keep_curr,layerdesign delete_virtual_residues_after_FastRelax=1/> 
<Dssp name=dssp/> 
       </MOVERS> 
        <OUTPUT scorefxn=talaris2014_cart/> 
 
        <APPLY_TO_POSE> 
        </APPLY_TO_POSE> 
 
        <PROTOCOLS> 
          design 
          <Add mover_name="ACM"/> 
          <Add mover=fastrelax/> 
 
          to save time 
          <Add filter=must_have_core_res/> 
 
          real filters 
          <Add filter=bunsat/> 
          <Add filter=cav_vol/> 
          <Add filter=charge/> 
          <Add filter=env/> 
          <Add filter=exposed/> 
          <Add filter=faulty_fragments/> 
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          <Add filter=holes/> 
          <Add filter=nres/> 
          <Add filter=packstat/> 
          <Add filter=percentage_of_ala/> 
          <Add filter=rmsd/> 
          <Add filter=score_norm/> 
          <Add filter=ss_sc/> 
          <Add filter=sspred/> 
       </PROTOCOLS> 
</ROSETTASCRIPTS> 
 
Flags 
-s 
/nas02/home/k/i/kimdn/lustre/side_chain_design/a_slash_b/w_max_4_loop_res_5_edge_res/led_to_E1_8/make_input_dirs/input_files/278711_5
_1.pdb 
 
-holes::dalphaball /nas02/home/k/i/kimdn/db/DAlphaBall_sheffler/DAlphaBall.gccstatic 
 
-jd2:delete_old_poses 
-jd2:mpi_work_partition_job_distributor 
-ignore_unrecognized_res 
 
-nstruct 1 
-packing:linmem_ig 10 
-relax:constrain_relax_to_start_coords 
 
-mpi_tracer_to_file mpi_tracer 
-overwrite 
-mute core 
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Resfile 
ALLAAxc 
USE_INPUT_SC 
start 
1 A NOTAA CP 
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